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Abstract
Selenium is a required trace element which was originally discovered by the
Swedish chemist Jons Jacob Berzelius in 1817. It was initially believed to be a toxin as it
was identified as being the cause of hoof maladies and excessive hair loss in horses that
feed upon plants with high selenium content. It wasn’t until 1957 that the potential
contributions of selenium to physiology were first demonstrated. Selenium is now known
to play a critical role in the maintenance of human health. Interestingly, unlike other trace
metals/semi-metals, selenium is directly incorporated into proteins in the form of the
amino acid selenocysteine (Sec) in a very complicated and energetically costly fashion.
Though rare, being found in only 25 human proteins, Sec proteins are involved in
numerous vital biological processes including maintenance of redox homeostasis and
anti-oxidant defense. Even though Sec is essential, the reason that Sec replaces its
structural analog cysteine (Cys) in only 25 proteins is not widely agreed upon. A previous
model suggests that the replacement of Cys with Sec provides enzymes with a type of
catalytic advantage. The presence of Cys-containing orthologs of mammalian Secenzymes in other eukaryotes argues against this model. A newer model to explain the use
of Sec is that the gain of function imparted to an enzyme by replacing Cys with Sec is the
ability of Sec to impart chemical reversibility.
Building on previous results from our lab demonstrating the ability of Sec to
confer proteins with the ability to resist over oxidation we have elucidated the mechanism
by which Sec containing thioredoxin reductase (TrxR) resists over oxidation. The ability
of Sec-TrxR to resist oxidative inactivation is due to the greater electrophilicity of Sec
relative to Cys. This allows for quicker resolution and prevents over oxidation. Based on
these findings we also investigate the utility of the alkylating agent dimedone to probe the
oxidation state of Sec. Interestingly, it was discovered that dimedone will react with
seleneninic acid with the resulting adduct being labile. Additonally it was discovered that
dimedone will also react with seleninic acid, resulting in the formation of a dimedone
dimer. These results call into question the usefulness of dimedone in deteremining the
oxidation state of Sec. Finally, we provide evidence that Sec-TrxR enzymes are able to
catalyze single electron reductions. This is most likely due to the formation of a stable
Sec radical intermediate. As a whole this project provides support for the theory that Sec
was selected for due to its ability to convey chemical reversiablity to proteins.
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Chapter 1:
Selenocysteine: The 21st Proteinogenic
Amino Acid

The 21st amino acid selenocysteine
Figure 1: Selenocysteine (A) and it’s structural analogue Cysteine (B). The only
difference between these two amino acids is that in selenocysteine selenium (Se) replaces
the sulfur (S) that is present in cysteine. The incorporation of selenium imparts unique
properties to the amino acid. The physiological advantages of selenocysteine are
currently under debate.

1

Selenium and Physiology
Selenium is a required trace element which was originally discovered by the
Swedish chemist Jons Jacob Berzelius in 1817 (1). It was initially believed to be a toxin
as it was identified as being the cause of hoof maladies and excessive hair loss in horses
that fed upon plants high in selenium content (2). It wasn’t until 1957 that the potential
contributions of selenium to physiology was first demonstrated (3). Selenium is now
known to play a critical role in mammalian development and boosting immune function
(4,5,6). While selenium deficiency in mammals has been linked to white muscle disease,
hepatosis dietetica, pancreatic degeneration, and reduced male fertility (7). Selenium
deficiency is uncommon in humans; however, it is associated with the development of
Keshan disease, a type of cardiomyopathy, and Kashin-Beck disease, a type of
osteochondropathy (8,9).
Selenium is utilized by numerous organisms in various forms. Selenium can be
found incorporated into bacterial tRNA in the form of 5-methylaminomethyl-2selenouridine and used in translation (10). Selenoneine, a selenium analog of the
antioxidiant ergothioneine, is found in tuna (11). Plants growing in soil containing
selenium will take it up and metabolize selenium into various species including the amino
acids selenomethionine (SeMet), selenocysteine (Sec) and selenomethylselenocysteine,
as well as the inorganic selenite, selenate (as reviewed in 12). A complete list of
abbreviations used in this dissertation can be found in Appendix A. In mammals
selenium is an essential trace element but unlike other trace metals/semi-metals it is
2

directly incorporated into proteins in the form of the amino acid Sec. Interestingly,
different from all other proteinogenic amino acids which are made prior to
aminoacylation, selenocysteine is directly synthesized on its transfer ribonucleic acid
(tRNA). The acceptor tRNA, tRNA(Sec)Ser, is initially aminoacylated with serine (Ser) by
the enzyme seryl-tRNA synthetase (SerRS) in a reaction requiring the use of adenosine
triphosphate (ATP) (13,14). Once attached, the hydroxyl group of Ser is replaced by a
phosphate group by the enzyme O-phosphoseryl–tRNA kinase (PTSK) forming Ophosphoseryl–tRNASec (Sep-tRNASec) in a reaction that requires another molecule of
ATP (15). In the final step Sep-tRNASec reacts with the selenium donor selenophosphate
to form Sec-tRNASec in a reaction catalyzed by the enzyme O-PhosphoseryltRNA:selenocysteinyl-tRNA synthase (16). The selenium donor molecule is generated
from the reaction of selenide with ATP. This reaction is catalyzed by the enzyme
selenophosphate synthetase 2 (SPS2) (17). The incorporation of selenium into a protein is
further complicated by the use of a stop codon, UGA in humans, as the codon for Sec
(18, 19). To differentiate the use of UGA as a Sec codon from a stop codon a mechanism
involving a stem loop structure present in mRNA of selenoproteins. The stem loop
structure, known as the Sec incorporation sequence (SECIS) element, is found in the 3’
untranslated region of mRNA in eukaryotes (20). In prokaryotes the SECIS element is
found in the coding sequence of the mRNA, 3’ to the UGA codon (21). The SECIS
element is recognized by an additional factor, the SECIS element binding protein 2
(SBP2) (22). SBP2 binds to the SECIS element and recruits the Sec specific elongation
factor EFSec which is then able to successfully incorporate Sec into a grown peptide chain
3

(23). This process is illustrated in Figure 2. The machinery necessary for the successful
incorporation of Sec is found in the three domains of life (24,25).
Currently, twenty-five Sec containing proteins (Table 1) have been identified in
the human proteome (26). All selenoproteins only contain a single Sec residue except for
selenoprotein P which contains ten Sec residues (27). The individual functions of all
twenty-five proteins are unknown. However most of the proteins that have been
characterized are involved in antioxidant defense and the maintenance of redox
homeostasis. Additionally, selenoproteins are also involved in the modulation of thyroid
hormone activity, amino acid repair, transport and storage of selenium, and protein
folding (as covered in the reviews 28, 29). Due to the range and importance of the
functions of selenoproteins, deficiency in these proteins is linked to the pathogenesis of
numerous diseases.
Glutathione peroxidases are a family of eight enzymes, 5 of which are
selenoproteins (30). These enzymes catalyze the reduction of hydrogen peroxide and
other organic peroxides (31), as well as lipid peroxides (32). Due to the important role
that these enzymes play in antioxidant defense, deficiencies in these proteins have been
linked to the pathogenesis of many diseases including diabetes, cancer, obesity,
Alzheimer disease and Parkinson’s disease (33, 34, 35, 36, 37, 38).
Thioredoxin reductases (TrxR), another family of selenoproteins, are also
involved in redox homeostasis. Additionally, these enzymes are involved in nucleic acid
synthesis, gene expression, and amino acid repair (39, 40, 41). TrxRs role in these
processes is indirect and facilitated by its canonical substrate thioredoxin (Trx). TrxR
4

also plays a direct role in regulating oxidative stress in the thyroid in response to iodide
stress (42). Deficiencies in TrxR have been linked to a variety of disease including
cancers, and cardiovascular and neurodegenerative diseases. TrxR will be discussed in
greater detail later in this chapter.
The iodothyronine deiodinases are another class of well characterized Sec
proteins. This family of enzymes consists of 3 integral membrane proteins that catalyze
the metabolism of the thyroid hormones (43,44,45,20). Deficiencies in these enzymes has
been linked to the development of endocrine disorders (46, 47, 48). Not all selenoproteins
have been well characterized. However, it is clear from the selenoproteins that have been
studied in depth that selenium, and more specifically, Sec plays a vital role in human
physiology.

Selenocysteine Vs Cysteine
Sec incorporation into proteins is a complicated and energetically costly process
requiring the synthesis of additional factors. Where as the incorporation of the sulfur
containing Sec analogue cysteine (Cys) is much less complicated and does not require
additional machinery. Given this, it is not surprising that Cys, with 214,000 residues
encoded in the human proteome (49), is much more common than Sec with just 34
residues in the human proteome (26). Both sulfur and selenium are chalcogens, found in
group 16 of the periodic table. These elements do have similar chemical properties
however given that Sec replaces Cys in 34 instances and the costly mechanism of its
incorporation it must impart some advantage to a protein that Cys cannot.
5

Though similar in their chemical properties sulfur and selenium are not identical.
Selenium is larger with an atomic radius of 115 picometers (pm) compared to an atomic
radius of 100 pm for sulfur (26). This difference is size results in selenium being more
polarizable then sulfur. Do to the increased polarizability of selenium, bonds to this
element are weaker then bonds to sulfur. Furthermore, the increase in polarizability also
results in selenium being both a better nucleophile and electrophile then sulfur (50).
These chemical differences between selenium and sulfur result in the amino acids Sec
and Cys having different properties as well. One such difference is the pKa values of the
free amino acids. Due to the increased size and polarizability of selenium relative to
sulfur, hydrogens are more weakly bound to selenium which results in an Sec being more
acidic then Cys (26). The pKa of the cysteine thiol is approximately 8.3 while the pKa of
the Sec selenol is 5.25 (50). At physiological pH this results in Sec primarily being found
in the selenolate form while Cys will remain protonated and in the thiol form. The fact
that at physiological pH the vast majority of Sec will be in the more active selenolate
form coupled with the greater nucleophilicity of selenium relative to sulfur suggests a
potential advantage of Sec. This advantage in reactivity has been demonstrated at both
physiological and acidic pHs (51, 52). However, the pKa of Cys can be altered
significantly by the protein micro-environment. Reactive Cys residues that are found in
proteins often have much lower pKas then that of the free amino acid. This is the result of
protein structural features that would stabilize the negatively charge thiolate (53, 54, 55).
The pKa of reactive Cys residues found in proteins have been measured to be
significantly lower than that of the free amino acid (56, 57) and have been detected to be
6

as low as 2.5 (58). The ability to alter the pKa and nucleophilicity of Cys may indicate a
reason as to why Cys orthologues of Sec enzymes exist (59, 60).
In addition to being a better nucleophile with a lower pKa, selenium is also a
better electrophile then sulfur. This is due to the increased strength of hypervalent
bonding, relative to sulfur, that occurs with selenium (61,62). This allows for quicker
nucleophilic attack on selenium due to the formation of a more stable intermediate (63,
64, 65). This property has been shown to be important in how the enzyme TrxR works.
The Sec residue in mammalian TrxR has been shown to act as an electron acceptor
during catalysis (66). When truncated enzyme missing its Sec containing active site was
assayed with selenocystine, there was significantly higher activity then when cystine was
used as a substrate (67). In utilizing these substrates, the investigators were attempting to
model an electrophilic step of the enzymes mechanism. The loss of selenium and the
resulting decrease in electrophilicity of the substrate cystine was responsible for the
significant decrease in enzyme activity. This result suggests Sec is important in the
mechanism of TrxR due to its electrophilicity.
However, Cys orthologues of this enzyme do exist. In Cys orthologues of TrxR it
has been demonstrated that these enzymes can potentially compensate for the loss of Sec.
This has been demonstrated in the Cys TrxR from Drosophila melanogaster. This
enzyme can enhance the electrophilicity of Cys through an electron withdrawing
interaction with a nearby histidine residue (68). Due to the enhanced electrophilicity of
selenium, mechanisms to increase electrophilicity are not required in Sec TrxR. The Cys
mutant of mammalian TrxR has very little thioredoxin reductase activity due, in part, to
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mammalian TrxR needing no compensatory mechanism to enhance the electrophilicity of
Cys (68). Though there is a difference in electrophilicity between selenium and sulfur,
proteins can enhance Cys electrophilicity to compensate for some of this difference.
Another interesting difference between Sec and Cys involves the stability of the
corresponding radical species (Figure 3). It has been demonstrated that selanyl radicals
formed in a peptide are more stable than the corresponding thiyl radicals (69, 70). This
increased stability prevents the selanyl radical from oxidizing adjacent residues where as
thiyl radicals will (70). This difference may be biologically significant as it has been
shown that selenium containing TrxR from rat liver can reduce the ascorbyl radical (71)
and cytochrome c (72). Furthermore, the ability to of mitochondrial TrxR to reduce
cytochrome c has been showing to be cytoprotective in the case of electron transport
chain inhibition. Specifically, with pharmacological inhibition of cytochrome c reductase
(complex III), cells over expressing TrxR were more viable then cells that did not (72).
This finding indicates that TrxR may serve as alternative mechanism through which
electrons can flow through the electron transport chain. TrxRs ability to reduce the
radical may also be physiologically important as ascorbate is acquired through diet. TrxR
provides a mechanism by which the cellular stores of ascorbate can be regenerated. The
dependence of TrxR on selenium to catalyze these single electron reductions is unknown
however the increased stability of the selanyl radical relative the thiyl radical may impart
and advantage to Sec containing TrxR.
A further advantage of Sec is the gain of peroxidase activity. This was first shown
through the chemical conversion of the catalytic serine residue of the protease subtilisin
8

into Sec. This resulted in the enzyme no longer functioning as a protease, but instead
acting as a peroxidase (73). This gain of function has also been demonstrated in other
proteins including glutaredoxin, trypsin, and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (73, 74, 75). The ability of Sec to impart peroxidase activity to an enzyme is
due to selenium’s superior nucleophilic and electrophilic character. The nucleophilic
character of Sec allows it to readily react with an oxidant such as hydrogen peroxide.
However, the electrophilic character allows Sec to be easily reduced backed to its initial
state (50). The ability of Sec to readily react with oxidant and then be reduced back
allows it to function as a peroxidase. The recognition of this quality lead to the
development of the theory that Sec confers resistance to overoxidation (76).
Evidence in support of this theory was provided through the study of wild type
(WT) Cys and Sec TrxRs and their corresponding selenium and sulfur mutants. It was
demonstrated that the selenium enzymes were far more resistant to oxidative inactivation
then the sulfur enzymes (77). Subsequently it was demonstrated that the ability of Sec to
convey resistance to oxidative inactivation has been demonstrated in other proteins as
well including hydrogenases. In these enzymes selenium, provided by Sec, acts as a
ligand for the nickel-iron clusters found in these enzymes. These enzymes are generally
resistant to oxidative inactivation (78). However, it was discovered that synthetic sulfur
analogs of these enzymes will inactivate when treated with oxidant (78) while the
corresponding selenium enzymes will not (79).
Though the theory that Sec conveys resistance to oxidative inactivation is a
relatively recent hypothesis it was first noted in 1992 that selenium maybe utilized to
9

prevent enzyme inactivation (80). This study found that the Cys mutant of the Sec
enzyme glutathione peroxidase-1 (GPx1) was readily inactivated in the presence of
hydrogen peroxide, the natural substrate for the enzyme (80). It was unknown at the time
how the enzyme was being inactivated but it was theorized that the Cys residue was
being overoxidized. Subsequent studies of rat GPx4 provided evidence of how the Cys
enzyme was being inactivated. In these studies, the WT Sec enzyme GPx4 and the Cys
mutant were treated with hydroperoxide. When the oxidation states of these enzymes
were analyzed using mass spectrometry (MS) it was discovered that the Sec residue of
the WT enzyme was still in an active form. While the Cys residue of the mutant enzyme
was found to be irreversibly oxidized to sulfonic acid (RSO3-) (81). The greater ability of
Sec to resist overoxidation maybe in part due to its greater electrophilicity as well as its
ability to reduce higher oxidation states of selenium relative to sulfur. This was first
demonstrated in the Sec mutant of subtilisin. It was discovered the enzyme could be
oxidized to seleninic acid (RSeO2-). The enzyme was not inactivated as addition of
reductant allowed the enzyme to be reactivated (82). A similar result was found in the
Sec mutant of GAPDH in which the Sec residue was found to be oxidized to RSeO2- but
was not inactivated (74). It is known that the WT Cys GAPDH is inactive when the
catalytic Cys residue is oxidized to sulfinic acid (RSO2-,) (83). A comparison of the
oxidation states of Sec and Cys can be found in Figure 4. Further evidence of the ability
of Sec proteins to utilize higher oxidation states was provided through the study of
truncated TrxR. These enzymes lack the C-terminal redox site which will either contain a
catalytic Sec or Cys residue depending on the species from which the enzyme was taken.
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In these experiments truncated TrxR was assayed with methaneseleninic, a stable
seleninic acid compound. The truncated enzyme could reduce this compound. When the
sulfur analog, hydroxymethanesulfinate, was used as a substrate it was determined that
the enzyme could not reduce this compound (84). These results suggest that Sec enzymes
maybe able to utilize higher oxidation states, however no evidence exists of this
occurring in WT selenoproteins. While there is no evidence of seleninic acid use in
nature, sulfinic acid formation in WT Cys proteins is known to occur. Unlike seleninic
acid, sulfinic acid cannot be reduced by thiols and are generally not reversible. However,
in case of the peroxiredoxins, WT Cys peroxidases, sulfinic acid has been shown to be
repairable. Interestingly, the reduction of sulfinic acid in peroxiredoxins requires
sulfiredoxin, a specific repair enzyme, that utilizes ATP to reduce the overoxidized
catalytic Cys residues (85).
The ability of Sec to confer resistance to overoxidation is a potentially significant
advantage over Cys. Until recently the ability to of Sec to resist overoxidation was only
investigated in vitro so the physiological relevance of this quality was unknown. A recent
study has demonstrated that the ability of Sec to confer oxidative resistance to proteins is
important for the maintenance of proper function in mice (86). In this study Conrad and
co-works engineered a mouse that expressed a Cys mutant of the WT Sec enzyme GPx4.
This enzyme is protective against oxidative stress as it acts as both a hydroperoxidase and
lipid peroxidase. The mice that were homozygous for the Cys GPx4 were found to suffer
from epileptic seizures and by day 18 all of these mice had to be euthanized. Mice that
were homo or heterozygous for the WT Sec GPx4 did not suffer from seizures and were
11

healthy. It was discovered that the cause of the seizures in the Cys GPx4 expressing mice
was the result of the death on a particular set of gamma-aminobutyric acid (GABA) interneurons. The researchers believed that the loss of these GABAergic inter-neurons was the
result of an inability to deal with oxidative stress due to the loss of the WT GPx4 enzyme.
In order to determine if this was the case the researchers cultured mouse
embryonic fibroblasts (MEF) expressing WT GPx4 or the Cys mutant and exposed the
MEFs to hydrogen peroxide or tert-butyl hydroperoxide. It was discovered that MEFs
expressing the Cys mutant enzyme readily died when treated with oxidant while the cells
expressing WT GPx4 were significantly more resistant to oxidant treatment. In order to
determine why the MEFs expressing the Cys mutant enzyme were more likely to the die
when treated with oxidant, the researchers purified Cys GPx4 or WT Sec GPx4 from
MEFs treated with oxidant. It was discovered that in the mutant enzyme, the catalytic Cys
residue irreversibly oxidized to RSO3- resulting in the inactivation of the enzyme. While
in the WT enzyme the catalytic Sec residue was found to be unoxidized and thus the
enzyme was still active. The investigators concluded that the oxidative inactivation of
Cys GPx4 resulted in a decrease in the ability of the MEFs and GABAergic interneurons
to deal with oxidative stress. The decreased ability to deal with oxidative stress
subsequently resulted in cell death (89). This study is very significant as it is the first to
demonstrate in vivo that a potential reason for the evolutionary selection of selenium is
due to its ability to confer resistance to oxidative inactivation. Prior to this study only in
vitro evidence of this benefit existed. Coupling this new in vivo evidence with the
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substantial amount of in vitro evidence suggests that one of the major benefits Sec has
over Cys is its ability to confer resistance to oxidative inactivation.
There exist chemical differences between selenium and sulfur. Some of these
differences such as electrophilicity, pKa and nucleophilicity can to some extent be
compensated for in a protein. This complicates the question as to what the advantage Sec
confers to a protein that Cys cannot. Due to the costly mechanism by which Sec is
incorporated in to an enzyme it must impart some advantage. Two promising theories as
to why Sec has been selected for are 1) its ability to resist oxidative inactivation and, 2)
its ability to form stable radicals allowing it to catalyze single electron reductions. In the
case of Sec conferring resistance to oxidative inactivation the phycological relevance of
this has recently been demonstrated. While the ability of Sec enzymes to catalyze single
electron transfers may be an additional benefit that needs to be explored further. It maybe
that Sec was not selected for one reason, but was chosen as it imparts several benefits to a
protein that Cys cannot. The ability to elucidate these benefits has been complicated,
historically, by the difficulty in acquiring selenoproteins. Because of this, the study of
selenoproteins has focused on just a few proteins such as TrxR. This enzyme has been
instrumental in establishing the importance of Sec and will be discussed in detail in the
following sections.

Thioredoxin Reductase and the Thioredoxin System
TrxR is a ubiquitous enzyme which along with NADPH and Trx compose the
thioredoxin system. This system was originally discovered in 1964 as a hydrogen donor
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for ribonucleotide reductase (39) however it is now known to be involved in numerous
critical biological process. Because of its importance in proper physiological functioning,
deficiencies in this system have been linked to the pathogenesis of numerous diseases. In
this section I will focus on the mammalian thioredoxin system and its biological
significance.
As mentioned above, the mammalian thioredoxin system is composed of TrxR,
Trx, and NADPH. Multiple isoforms of Trx and TrxR exist and are found in specific cell
types or organelles. There are three isoforms of Trx. A cytosolic form, mitochondrial
form, and an isoform that is highly expressed in spermatozoa (87). The cytosolic form of
Trx can under certain conditions be translocated to the nucleus or exported into the extra
cellular matrix (88,89). All three isoforms of Trx are members of the thioredoxin super
family of proteins all of which are characterized by a common motif known as a
thioredoxin like fold. In addition to Trx, other members of the thioredoxin super family
include glutaredoxins and GPx enzymes (90). Members of this family can catalyze the
reduction of disulfides. The active site of Trx is composed of the conserved sequence
CXXC. The N-terminal Cys residue is solvent exposed and has a low pKa that is
approximately 2 or more pKa units lower than that of the free Cys. In contrast the Cterminal Cys is buried and has pKa that is higher than that of the N-terminal Cys (91,92).
Trx reduces proteins by first binding non-covalently to a hydrophobic patch
around the target disulfide. Once bound to the target the N-terminal thiolate will act as a
nucleophile and attack the disulfide of the target protein. This results in the formation of
an intermolecular disulfide between Trx and the target protein which is then resolved by
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the C-terminal Cys of Trx. Upon resolution of the mixed disulfide, the target protein
disulfide is reduced to a dithiol and Trx is oxidized to a disulfide (93). The oxidized form
of Trx is reduced by TrxR which uses electrons from NADPH to reduce Trx. This is a
critical step as the oxidized form of Trx is inactive and thus can no longer reduce various
target proteins.
The thioredoxin system plays a key role in proper cellular function. One such
critical process is DNA synthesis. As mentioned previously Trx was initial identified as
providing the reducing equivalents for ribonucleotide reductase. Ribonucleotide
reductase catalyzes the reduction of various ribose nucleotides to their deoxyribose
nucleotides. Trx has been shown to be an important in vivo electron donor for this
reaction (94). In addition to DNA synthesis the thioredoxin system also plays a key role
in the repair of oxidized methionine residues. Methionine sulfoxide reductases are
enzymes that will reduce methionine sulfoxide back to methionine. Trx provides the
reducing equivalents for these enzymes (95).
The thioredoxin system also plays a central role in redox homeostasis. It does this
in several ways. One way in which the thioredoxin system contributes to redox
homeostasis is the direct scavenging of reactive oxygen species by TrxR. TrxR has been
shown to directly reduce both peroxides and lipid peroxides (96, 97). In addition to
directly reducing reactive oxygen species TrxR is capable of reduce and regenerating
various anti-oxidants including ascorbate as mentioned in the previous section as well as
lipoic acid (98). Trx also plays a role in redox homeostasis as it provides the reducing
equivalents for peroxiredoxins, a family of enzymes that turnover peroxides (99, 100).
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Trx is also involved in the modulation of the activity of various redox sensitive
transcription factors including NF-κB, tumor suppressor p53, and HIF-1.
Due to the thioredoxin systems key role in numerous process and the ability to of
Trx to modulate the activity of various transcription factors, the thioredoxin system is
implicated in the pathogenesis of numerous diseases. Various types of cancer have been
found to over express both TrxR and Trx as these proteins play an important role in
protection against oxidative stress and apoptosis (101,102). Because of the importance of
the thioredoxin system in cancer pathogenesis it has been identified as a therapeutic
target (103,104). In addition to cancer the thioredoxin system has been shown to play an
important role in neurodegenerative diseases. In mouse models of Parkinson’s disease, a
decrease in TrxR levels has been observed (105). Furthermore, it has been demonstrated
that deficiencies in TrxR result in dopaminergic cell death (106). Down regulation of
TrxR has also been demonstrated in mouse models of Alzheimer’s disease (107).
Oxidative stress plays an important role in the development of neurodegenerative
diseases and disruption of the thioredoxin system most likely impairs the ability of
neurons to modulate their redox state (108). Impairment of the thioredoxin system has
also been implicated in the development of diabetes. A decrease Trx and TrxR expression
in the liver has been demonstrated in mice fed high fat diets and may contribute to the
increased oxidative stress and development of diabetes (109). Furthermore, transgenic
mice overexpressing Trx have been shown to have increased resistance to oxidative
destruction of pancreatic β-cells which is believed to be a key role in the development of
diabetes (110). All of these diseases are in some way related to oxidative stress and
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alterations in the thioredoxin system. Whether it is an increase in activity of the system as
seen in various types of cancers or a decrease in activity which is observable in
neurodegenerative diseases and diabetes, the critical role the thioredoxin reductase
system plays in dealing with oxidative stress and maintenance of redox homeostasis is
evident.
The thioredoxin system plays a critical role in cellular function. A major
component of the system is TrxR. As mentioned above TrxRs role in the thioredoxin
system is to reduce Trx, activating it and allowing to modulate the activity of numerous
other proteins and physiologically significant process. An interesting aspect of all
isoforms of mammalian TrxR is their incorporation of the rare amino acid Sec. The
importance of Sec in mammalian TrxR is not well established and is complicated by the
fact that Cys orthologues of TrxR do exist. In the next section I will compare Sec TrxRs
and Cys TRs.

Thioredoxin Reductase: Selenium vs Sulfur
TrxR is a member of the pyridine dinucletide disulfide oxidoreductase family of
proteins. Interestingly, there are two distinct forms of TrxR found in nature. A low
molecular weight TrxR (TrxR-L) (~35 kDa) which is found in bacteria, archaea, most
single celled eukaryotes, and plants (as reviewed in 111). TrxR-L is structural related to
alkyl hydroperoxide reductase F52A (112). While a higher molecular weight TrxR (~55
kDa) (TR-H) has been found in animals, Drosophila melanogaster, Caenorhabditis
elegans, and Plasmodium falciparum (113,114,115,116). Unlike TrxR-L, TrxR-H is
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structurally related to glutathione reductase, trypanothione reductase, mercuric reductase,
and lipoamide dehydrogenase (117). Overall all there is only approximately 20%
sequence homology between the high and low molecular weight enzymes (118). Despite
the difference in sequence similarity all TrxRs are functional homodimers. Each
individual monomer contains a falvin adenine dinucleotide (FAD) prosthetic group, and a
nicotinamide adenine dinucleotide phosphate (NADPH) binding domain (119). High
molecular weight enzymes contain a redox active site in the FAD binding domain with a
motif of CXXXXC (118). Low molecular weight enzymes lack this site, but a redox
active site is found in the NADPH binding domain. The sequence of this motif is CXXC
(118). Furthermore TrxR-H have a C-terminal domain which is not present in TrxR-L.
This extended domain contains an additional redox site the sequence of which is species
specific. The mammalian enzyme sequence is GCUG in which the penultimate residue is
Sec. While the sequence of the Drosophila melanogaster enzyme is SCCS (120, 119).
The Plasmodium enzymes C-terminal redox site sequence is different from other TrxR-H
enzymes, having a sequence of CGGGKCG (116). As mentioned above mammalian
TrxR contains Sec while the enzymes from Drosophila melanogaster and Plasmodium
falciparum do not. Interestingly, TrxR like enzymes from some types of parasites,
including Schistosoma mansoni, also contain Sec (121).
Unlike Cys TrxRs, mammalian enzymes are dependent upon Sec to reduce their
canonical substrate thioredoxin. However, the general mechanism of the high molecular
weight enzymes is similar regardless of whether they are Cys or Sec enzymes (128).
TrxR is a functional homodimer that is arranged in a “head to tail” configuration During
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catalysis electrons from NADPH are transferred to the bound FAD which then reduces
the N-terminal redox site disulfide. Reduction of the disulfide results in the formation of
a dithiol. This part of the reaction very closely mimics the reaction mechanism of
glutathione reductase (GR) and other members of the dinucleotide disulfide
oxidoreductase family. However, unlike GR, which upon formation of a dithiol motif will
reduce a substrate such as oxidized glutathione, the reduced N-terminal redox site
reduces the C-terminal site selenosulfide or disulfide depending on the enzyme. The
resulting selenol or thiol is then capable of reducing various substrates including
thioredoxin. The mechanism of Sec TrxR is diagrammed in Figure 5. If an
intramolecular intermediate is formed between the enzyme and substrate, as is the case
with thioredoxin, the adjacent Cys residue resolves the intermediate (128). During the
catalytic mechanism of TrxR the Sec or Cys residue functions as both an acceptor of
electrons following reduction by the N-terminal redox site and a donor of electrons
during the reduction of substrate. As mentioned in the previous section there are chemical
differences between selenium and sulfur. To deal with the loss of selenium, Cys TrxRs
have developed compensatory mechanisms.
The study of the TrxR from Drosophila melanogaster, DmTrxR, has revealed
some mechanisms that allow Cys TrxRs to cope with the loss of selenium. As mentioned
in the general description of the catalytic mechanism TrxR-H, electrons from the nterminal redox site are transferred to the C-terminal site reducing the selenosulfide of
Sec-TrxR or the disulfide of Cys TrxR. In this reaction the Sec or Cys residue is acting as
an electrophile (66). Due to the decreased electrophilicity of sulfur relative to selenium,
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DmTrxR must compensate for this loss to maintain its catalytic efficiency (119). It has
been demonstrated that DmTrxR does this by polarizing the C-terminal disulfide. A
histidine residue located near the C-terminal redox disulfide interacts with the
antepenultimate Cys (122). Disruption of this interaction by replacing the
antepenultimate Cys with homocysteine has been shown to result in a significant loss of
activity DmTrxR (68). This result indicates that the interaction of histidine with the
antepenultimate residue is essential to catalysis. By losing the interaction of the histidine
with the antepenultimate Cys, the disulfide bond is no longer polarized. This loss of
polarization prevents the activation of the penultimate Cys by preventing it from
becoming electron deficient (68). By polarizing the disulfide bond, and enhancing the
electrophilicity of Cys, DmTrxR is able to enhance the rate of reduction of the C-terminal
redox site by the N-terminal redox site.
In addition to acting as an electrophile during TrxR catalysis the Sec residue also
acts as a nucleophile during reduction of substrate. Due to the greater nucleophilicity of
selenium relative to sulfur, Cys TrxRs need to compensate for this loss. It has been
shown in DmTrxR that the residues flanking the C-terminal Cys residues are essential for
the enhancement of Cys nucleophilicity (120). Unlike the mammalian enzyme which
contains the motif Glycine-Cys-Sec-Glycine, DmTrxR contains the motif Serine-CysCys-Serine. Replacement of the N-terminal serine in this motif with glycine results in an
enzyme with approximately 90% activity relative to the WT enzyme. While replacement
of the ultimate serine residue with glycine results in an enzyme with only about 30% of
the activity of WT DmTrxR (120). It is theorized that the Cys residue thiols hydrogen
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bond with the hydroxyl groups of the adjacent serine residues. These interactions, along
with a nearby histidine residue, help to facility the deprotonation of the thiol groups
(120). This is important as the pKa of the unperturbed Cys thiol is approximately 8.5.
This would suggest that the serine residues help to lower the pKa allowing for the Cterminal Cys residues of DmTrxR to more readily be deprotonated and thus facilitate the
formation of the active thiolate (120). The differing effects of mutating the N-terminal
serine to glycine compared to altering the C-terminal serine to glycine reveals the
differing role the two Cys residues play in catalysis. The penultimate Cys residue is
responsible for reducing substrates such as thioredoxin (128). By preventing the
interaction of the serine hydroxyl with the Cys thiol, there is no lowering of pKa and thus
no facilitation of thiolate formation. This would significantly impair the ability of the
enzyme to reduce substrate as the thiolate is the active nucleophile. Mutation of the Nterminal serine did reduce activity but by much less than the ultimate serine residue. The
antepenultimate Cys residue is responsible for resolution of intermolecular bonds with
substrates such as thioredoxin (120). Facilitation of thiolate formation would also be
important as the thiolate again is the active nucleophile. Mammalian TrxR does not
require a Sec flanking serine residue due to already comparatively low pKa of the Sec
selenol, approximately 5.25, which allows for the vast majority of Sec to be deprotonated
and in the active selenolate form at physiological pH. Just as in DmTrxR, the
antepenultimate Cys residue resolves intermolecular bonds between substrate and Sec.
Interestingly the n-terminal flanking residue is glycine and not serine suggesting that the
enzyme does not need to facilitate thiolate formation of the C-terminal Cys residue. This
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may be do to the increased electrophilicity of selenium which would serve to facilitate the
nucleophilic attack by the adjacent Cys residue. Even though only a fraction of the
unperturbed Cys residue would be in the active thiolate form, the electrophilicity of Sec
maybe able to compensate. This is supported by the finding the mutation of the nterminal serine in DmTrxR results in only a 10% loss of activity (120). Thiolate
formation of the antepenultimate Cys does not appear to be necessary for catalysis but it
does serve to enhance enzyme activity. The reason DmTrxR promotes thiolate formation
of this Cys residue is most likely to compensate for decreased electrophilicity of sulfur
relative to Sec.
The TrxR from Plasmodium falciparum is another Cys containing TrxR.
However, unlike DmTrxR, the C-terminal redox site motif does not feature Cys residues
flanked by serine residues. The sequence of C-terminal redox site of Plasmodium
falciparum TR (PfTrxR) is GCGGGKCG. Because the C-terminal redox site of this
enzyme is different than that of DmTrxR it must have an alternative mechanism of
compensating for the decreased reactivity of Cys. Initially, it was believed that the
antepenultimate lysine residue acted as an acid-base catalyst that would help to enhance
the nucleophilicity the adjacent Cys residue. This was believed in part due to the crystal
structure of PfTrxR showing lysine interacting with serine71 (123). However, mutation
of lysine residue to alanine resulted in only a small decrease in enzyme activity
suggesting very little contribution of this interaction on enzyme function (124). Previous
investigations into the structure and functions of TrxR-H has indicted that a salt bridge
forms between the ultimate glycine residue and lysine58 (123,125). In PfTrxR this
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interaction was believed to act as a tether that would help facilitate the reduction of the Cterminal redox site. However, the insertion of an additional glycine residue to the end of
the enzyme did not result in any change to enzyme activity (124). This result indicates
that the salt bridge does not play an important role in the enzymes mechanism as the
insertion of a glycine residue would disrupt this interaction (124). Interestingly the crystal
structure of PfTrxR also releveled a hydrogen bond between the amide NH group of
glycine541 and the carbonyl of glycine534. Deletion of glycine541 was found to result in
a significant decrease in enzyme activity suggesting that this interaction is very important
to enzyme catalysis (124). In the crystal structure of the enzyme, the C-terminal redox
site is found in a β-turn-β motif and the hydrogen bonding between glycine residues 534
and 541 play an important role in stabilizing this motif (123). As disruption of this
interaction has been shown to result in a significant decrease in the ability of PfTrxR to
reduce Trx, the β-turn-β motif may play an important role in catalysis. Further evidence
of the importance of this motif has been shown by altering the length of the C-terminal
redox site. Oxidation of the C-terminal redox site of PfTrxR results in the formation of a
20-membered ring. It has been shown that decreasing the ring size to 17 greatly decreases
the ability of PfTrxR to reduce Trx (124). Increasing the potential ring size to 23 has also
been shown to result in a significant decrease in Trx reductase activity (124).
Interestingly replacing the c-terminal redox site of the Plasmodium enzyme with the Cterminal site of the mammalian enzyme, GCUG, results in an enzyme with more Trx
reductase activity then the WT enzyme (124). Conversely replacing the C-terminal redox
site of PfTrxR with GCCG results in an enzyme with little Trx reductase activity (124).
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By replacing the C-terminal redox site of PfTrxR with either GCUG or GCCG the β-turnβ motif would be disrupted. The function of the β-turn-β motif maybe to strain the cterminal redox disulfide thus “activating” it for reduction by the N-terminal redox site
(124). Disruption of this motif, either through its destabilization, or by altering the ring
geometry of the oxidized C-terminal redox site may preventing strain of the C-terminal
disulfide. The ability of PfTrxR-GCUG to reduce Trx is suggestive of the chemical
advantage that Sec imparts to an enzyme. Other Cys TrxRs such as the mitochondrial
enzyme from Caenorhabditis elegans may use a similar β-turn-β motif to “activate” their
Cys containing C-terminal redox sites. However more research is required to determine
how these enzymes compensate for the loss of selenium reactivity.
Sec provides a chemical advantage as it is both a better nucleophile as well as a
better electrophile. This advantage is clear when looking at the compensatory
mechanisms that have been developed by Cys TrxRs in order to perform their enzymatic
functions. As discussed above the incorporation of Sec is energetically costly so the exact
benefits Sec imparts to an enzyme is an on-going question. The ability of Cys TrxRs to
compensate for the lack of Sec suggests that the advantage cannot be purely catalytic but
must result in some sort of additional gains of function over Cys. It is the goal of my
thesis work to investigate potential gains of function that Sec imparts to TrxR. These
goals will be discussed in the next section.
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Specific Aims
As discussed in the previous sections of this chapter the benefits that Sec confers
to proteins is an open question. Initially it was believed that Sec imparts a catalytic
advantage due to the lower pKa and superior nucleophilicity of Sec relative to Cys.
However, it is clear that enzymes are able to compensate for the loss of Sec reactivity as
Cys orthologs of Sec enzymes do exist. Our lab has developed a different theory as to the
benefit of Sec incorporation into proteins. Owing to the enhanced electrophilicity of Sec
and that most characterized Sec proteins play a role in redox homoeostasis we
hypothesized that Sec conveys resistance to oxidative inactivation (76). We provided
evidence for this hypothesis by exposing Sec and Cys TrxRs to various oxidants. Cys
enzymes readily inactivated when treated with oxidant while Sec enzymes retained most
of their activity (77). This result coupled with the recent study by Conrad (86) which
demonstrates our hypothesis in vivo provides significant evidence that Sec was at least
impart selected for its ability to convey resistance to oxidative inactivation. However, the
mechanism by which Sec containing enzymes resist overoxidation is an open question.
It seems that one benefit of Sec incorporation into proteins is its ability impart
resistance to oxidative inactivation an additional hypothesis for the incorporation of Sec
into proteins has been proposed by Koppenol (69). Koppenol has hypothesized that Sec
has been incorporated into proteins due to the increased stability of the selenium radical.
The increased stability prevents selanyl radicals formed in a peptide from oxidizing
adjacent residues while the corresponding thiyl radicals will (69, 70). This difference in
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stability may be biologically significant as it has been shown that selenium containing
TrxR from rat liver can reduce the ascorbyl radical (71) and cytochrome c (72). The
ability of TrxR to catalyze single electron reductions may be biologically important.
Ascorbate is an essential nutrient and TrxR maybe involved in maintaining cellular stores
of ascorbate. While the ability of TrxR to reduce cytochrome c has been shown to be
biologically significant (72). TrxR can catalyze single electron reductions however the
dependence of TrxR on Sec to catalyze these reactions is currently unknown.
It appears that Sec may impart multiple gains of function to TrxR. It is therefore
the goal of this project to further investigate the benefits that Sec conveys to TrxR with a
focus on the mechanism of oxidative resistance of Sec TrxRs and the dependence of
TrxRs on Sec to catalyze single electron reductions.
Aim 1 is to investigate the mechanism by which Sec TrxRs resist oxidative
inactivation. We hypothesis that the Cys residue in C-terminal motif, GCUG, of the
mammalian enzyme will act to resolve oxidation of the Sec residue. The function of this
residue in the reduction of Trx is to resolve the intermolecular selenosulfide that forms
between Sec and Trx during reduction. Therefore, we believe that it will function in a
similar manner and resolve oxidation of Sec residue as well. Because of the high
electrophilic character of Sec, resolution of oxidation will be fast. This will prevent over
oxidation and inactivation. Although the WT Cys DmTrxR also contains a Cys residue in
the same position of its C-terminal redox domain, SCCS, we believe that resolution of
oxidation of the C-terminal Cys will be much slower due to the decreased electrophilicity
of sulfur relative to selenium. This would result in and over-oxidation of the enzyme.
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First, we will confirm that overoxidation of the C-terminal redox site is responsible for
inactivation of TrxR. In order to do this, we will assess the oxidation states of the
DmTrxR and mTrxR following treatment with oxidant using mass spectrometry. Next,
we will create mutants of TrxR in which we increase the distance between the purposed
resolving Cys and the oxidized residue, Sec or Cys depending on enzyme. We would
expect by increasing the distance between the resolving Cys and the oxidized residue
would result in slower resolution and less resistance to oxidative inactivation. In order to
test resistance to over oxidation, these mutants will be exposed to oxidant and their
ability to resist oxidative inactivation will be measured. Additional mutants in which the
resolving Cys is changed to alanine will be created. We would expect that loss of this
residue would result in a significant decrease in resistance to oxidation. These
experiments will allow us to establish the mechanism by which Sec imparts TrxR with
resistance to over oxidation.
Aim 2 is to investigate the oxidation state of Sec in TrxR using the alkylating
agent dimedone. The ability of dimedone to stably label sulfenic acid is well established
(as reviewed in 126 and 127) however its reactivity towards various oxidation states of
selenium is unknown. Due to the ease at which Sec is oxidized and the role that most Sec
proteins play in dealing with oxidative stress, determining the ability of dimedone to act
as a probe for the oxidation state of Sec proteins is of great importance. In order to
establish the ability of dimedone to label selenenic acid, small Sec containing proteins
will be synthesized and reacted with hydrogen peroxide generating selenenic acid and
then reacted with dimedone. Labeling will be verified using mass spectrometry. Stability
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of the dimedone Sec label will be determined by adding reductants such as dithithertol
(DTT), 2-mercaptoethanol (βMe), and tris(2-carboxyethyl)phosphine (TCEP). These
reductants are commonly used during preparation of proteins for proteolytic digestion.
For dimedone to be a useful indicator of the oxidation state of selenoproteins it needs to
form a stable adduct. As a final goal of this aim we will determine the reactivity of
dimedone toward seleninic acid. Dimedone is known to specifically react with sulfenic
acid but will not react with higher oxidation states of sulfur. It may, however, react with
higher oxidation states of selenium. To determine if dimedone will react with seleninic
acid we will use the small molecule benzeneseleninic acid. The reaction between this
compound and dimedone will be monitored via nuclear magnetic resonance and mass
spectrometry.
Aim 3 is to determine the dependence of TrxR on Sec to catalyze single electron
reductions. Koppenol has hypothesized that Sec may be incorporated into proteins due to
the increased stability of the corresponding radical (69). In order to investigate the
dependence of TrxR on Sec to catalyze single electron transfers we will utilize Sec
mTrxR, Cys DmTrxR, and Cys PfTrxR as well as various Cys and Sec mutants of these
enzymes. These enzyme constructs will be assayed with the single electron substrates
cytochrome c and the ascorbyl radical as well as the potential one electron substrate
dehydroascorbate (DHAA). It is known that both cytochrome c and the ascorbyl radical
can be reduced by mTrxR (71,72). If the Cys mutant mTrxR is now longer able to reduce
these molecules it would suggest that TrxR is dependent upon Sec for single electron
reductions. Furthermore, if DmTrxR and PfTrxR cannot reduce these molecules but their
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Sec mutants could this would indicate TrxR requires Sec to catalyze single electron
transfers. Overall this would provide evidence for Koppenol’s hypothesis as well as
establish, along with increased resistance to oxidative inactivation, a gain of function Sec
imparts to TrxR.
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Figure 2.

Figure 2. Recognition of the SECIS element. Because Sec is encoded by the stop codon
UGA, organisms need a signal to properly interpret this codon. That signal, the SECIS
element, is located in the 3’ untranslated region of mRNA in prokaryotes. The SECIS
element is recognized by additional factors such as SBP2 which can then recruit a Sec
specific elongation factor (EF-Sec). This will then allow for the proper incorporation of
Sec into a protein.
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Table 1.
Protein

Tissue Distribution

Glutathione peroxidase (GPx) family members
GPx1
GPx2
GPx3
GPx4
GPx6

Ubiquitous
Liver, gastrointestinal tract
Plasma
Testes
Olfactory Epithilium, embryos

Thioredoxin reductase (TrxR) family members
TrxR1
TrxR2
TrxR3

Ubiquitous
Ubiquitous
Testes

Iodothyronine deiodinases (DIO) family
DIO1
DIO2

Liver, Kidney, Ovary, Thyroid, Pituitary
Thyroid, Brain, Heart, Spine, Skeletal Muscle,
Kidney, Pancreas

DIO3

Placenta, Skin

Se-protein 15 and M Family
SelM
Sep15

Brain, Kidney, Lung
Prostate, Thyroid, Lung, Brain, Kidney, T Cells

Se-protein S and K family
SelS
SelK
Rdx proteins family
SelW
SelH

Numerous tissues, Plasma
Numerous tissues but highly expressed in Heart
Numerous tissues but highly expressed in muscle
Numerous tissues but mainly found in embryonic
tissue
Ubiquitous
Testes

SelT
SelV
Other selenium containing proteins
SelP
SPS2
SelR
SelN
SelI
SelO

Liver, Heart, Kidney, Brain
Liver
Heart, Liver, Kidney, Muscle
Ubiquitous
Numerous tissues but highly expressed in brain
Numerous tissues

Table 1. Table listing the 25 human Sec containing proteins and their tissue distributions.
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Figure 3.

Figure 3. Strucutres of the thiyl radical form of Cysteine and the selanyl radical form of
Selenocysteine.
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Figure 4.

Figure 4. The oxidation states of selenocysteine and cysteine and their reversibility. *
sulfinic acid is generally not reversible, however in the case of peroxiredoxins a repair
enzyme is able to utilize ATP to repair the oxidation.
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Figure 5.

Figure 5. TrxR is a functional homodimer. NADPH, the electron source for mTrxR,
transfers electrons to transfers electrons to the tightly bound flavin which reduces the Ntermial redox site Cys residues (panel 1). Once reduced the N-terminal redox site will
reduce the Sec containing C-terminal redox site (panel 2). The resduced Sec residue is
then able to reduce other substrates including thioredoxin (panel 3).
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CHAPTER 2:
The Mechanism by Which Mammalian
Thioredoxin Reductase Resists Oxidative
Inactivation

Figure 6. Purposed model TrxR resistance to over oxidation. We hypotheses that the increased
electrophilicity of selenenic acid allows for quick resolution by the adjacent Cys residue in
mTrxR2. This allows the enzyme to be protected from over oxidation. Whereas the sulfenic acid
intermediate is less nucleophilic and will not be resolved as fast. This would result in a greater
chance at over oxidation and inactivation.
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Here we demonstrate that the ability of Sec TrxRs to resist oxidative inactivation
is due to the rapid resolution of oxidation of the Sec residue. Cys TrxRs cannot readily
reduce oxidation of their catalytic Cys residue. As result these enzymes are further
oxidized and inactivated. The ability of Sec enzymes to reduce oxidation is due to the
increased electrophilicity of selenium relative to Cys. The elucidation of the mechanism
by which Sec TrxRs resist oxidative inactivation is significant as it strengthens the theory
that Sec may be incorporated into proteins to provide resistance to oxidative inactivation.
Sec Confers Resistance to Oxidative Inactivation
The theory that Sec conveys resistance to oxidative inactivation is a recent
hypothesis, however it was first observed in 1992 that selenium maybe able to prevent
enzyme inactivation (80). This was observed in the Cys mutant of the Sec enzyme GPx1.
The Cys mutant was readily inactivated in the presence of hydrogen peroxide, which is a
natural substrate for the enzyme (80). Based on this result it was theorized that the
enzyme was being inactivate because of overoxidation of the Cys residue. Further studies
utilizing rat Sec GPx4 provided the first evidence of how the Cys enzyme was being
inactivated. In these studies, the WT Sec enzyme GPx4 and the Cys mutant were treated
with hydroperoxide. When the oxidation states of these enzymes were analyzed it was
discovered that the Sec residue of the WT enzyme was not overoxidized and the enzyme
was still active. While the Cys GPx4 was found to be irreversibly oxidized and
inactivated (81). The ability of Sec to resist overoxidation is most likely due to the greater
electrophilicity Sec as well as its ability to utilize higher oxidation states. This was first
demonstrated in the Sec mutant of the protease subtilisin. The Sec mutant of subtilisin
37

does not function as a protease but instead can function as a peroxidase. It was discovered
that the enzyme could be oxidized to seleninic acid (SeO2-) and following addition of
reductant the enzyme regained its peroxidase activity (82). A similar result was found in
the Sec mutant of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (83).
Interestingly it is known that WT Cys GAPDH is inactivated when the catalytic Cys
residue is oxidized to sulfinic acid (SO2- ) (83). Additional evidence of Sec proteins being
capable of utilizing higher oxidation states was provided through the study of truncated
TrxR. These enzymes lack the c-terminal redox site, which is where the catalytic Sec or,
in certain species, Cys residue is located. In these experiments truncated TrxR was
assayed with methaneseleninic, a stable seleninic acid compound. The truncated enzyme
could reduce this compound. When the sulfur analog, hydroxymethanesulfinate, was used
as a substrate it was determined that the enzyme was unable to reduce this compound
(84). These results suggest that Sec enzymes maybe able to utilize higher oxidation
states. Currently no evidence exists of this occurring in WT selenoproteins.
While there is no evidence of seleninic acid use in nature, sulfinic acid formation
in Cys containing proteins is known to occur. Sulfinic acid, unlike seleninic acid, cannot
be reduced by thiols under physiological conditions and are generally irreversible.
However, one such case where sulfinic acid has been shown to be repairable is in the Cys
peroxidase enzyme peroxiredoxin. The reduction of sulfinic acid in these proteins
requires sulfiredoxin, a specific repair enzyme, that utilizes ATP to reduce the
overoxidized Cys residues (85).
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The physiological relevance of Secs ability to impart resistance to overoxidation
has recently been demonstrated (86). In this study, conducted by Conrad, mice expressing
either WT Sec GPx4 or the Cys mutant were generated. The mice expressing the mutant
enzyme suffered from seizures. To investigate what the cause of the seizures was mouse
MEF cells expressing either WT GPx4 or the Cys mutant were exposed to oxidant. Cells
expressing the Cys mutant enzyme readily died when treated with oxidant while the
MEFs expressing WT GPx4 did not. When the GPx4 enzymes were purified from MEFs
treated with oxidant it was discovered that in the mutant enzyme, the catalytic Cys
residue irreversibly oxidized to sulfonic acid resulting in the inactivation of the enzyme.
While in the WT enzyme the catalytic Sec residue was found to be unoxidized and thus
the enzyme was still active. The investigators concluded that the seizures in the mutant
mice was due to the oxidative inactivation of the Cys GPx4 (86).
The Conrad study along with the numerous in vitro studies on the ability of Sec to
resist oxidative inactivation provides support for our theory that Sec evolved to provide
protection against oxidative stress. However, the mechanism by which Sec confers
oxidative resistance to TrxR is unknown. In this study we utilize both Sec, mitochondrial
TrxR (mTrxR2), and Cys, DmTrxR, WT enzymes as well as mutant enzymes to
investigate the mechanism by which Sec TrxRs resist oxidative inactivation. We provide
evidence that the antepenultimate Cys residue of the C-terminal redox site acts to resolve
oxidation of Sec. While in the Cys enzyme this does not appear to readily occur happen.
This results in the overoxidation and inactivation of Cys TrxRs.

39

Methods
Peptide synthesis.
Peptides used in these experiments were synthesized as described previously
utilizing 2-chlorotritylchloride resin and standard Fmoc chemistry (129). Following
synthesis a mixture of 96:2:2 trifluoroacetic acid (TFA), triisopropylsilane (TIS), and
water was used to cleave peptides from resin. The cleavage volume was reduced by
evaporation under a stream of nitrogen gas and precipitated using cold diethyl either.
Once dry, the peptides were suspended in water with minimal acetonitrile and freeze
dried. Composition of peptides was determined using direct infusion atmospheric
pressure chemical ionization mass spectrometry.
Enzyme Production.
We have previously reported enzyme production and purification (77, 129, 124).
All enzymes are produced as recombinant intein-fusion proteins as previously described
(77, 132, 127). Sec enzymes were produced as follows: E. coli cells containing the
plasmid for a truncated DmTrxR- or mTrxR2-intein-chitin binding domain (CBD) were
grown in either TB or LB medium. The culture, containing 0.2 g/mL ampicillin, was
grown at 37 °C until the OD600 reached ~0.6. Cells were then cooled to 20 °C and
induced using 0.5 mM IPTG. Following induction cells were grown at 20 °C overnight
on a rotary shaker (200 rpm). Cells were then harvested by centrifugation. The bacterial
pellets were suspended in chitin buffer A [50 mM MOPS and 150 mM NaCl (pH 7.0)]
followed by lysis with pulse sonication. The slurry was again pelleted via centrifugation
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and the cleared lysate was loaded onto a chitin-agarose column that was pre-equilibrated
with chitin buffer A. Truncated TrxR with the intein-CBD was able to bind to the resin.
The column was then washed with chitin buffer A until the absorbance at 280nm of the
effluent was the same as that of the wash buffer. Additional washing with 0.5 L of highsalt chitin buffer B [50 mM MOPS and 500 mM NaCl (pH 7.0)] followed. Once washing
was complete the resin was removed from the column and enough chitin buffer B was
added to make a compact buffer-resin slurry.
Semisynthetic Sec-containing mTrxR enzymes were produced via ligation of the
desired peptides to the truncated mTrxR2 containing a C-terminal thioester group.
Cleavage of the fusion protein from the intein and ligation with synthetic peptide
occurred simultaneously by addition of a cocktail consisting of 120 mM N-methyl
mercaptoacetamide (NMA) as well as the desired peptide in chitin buffer B (pH 8.0−8.5).
Reactions were carried out overnight at room temperature with constant shaking.
Following the overnight incubation, the resin/chitin slurry was placed back onto the
column and the excess buffer was drained. 3 column volumes of chitin buffer B were
used to wash the resin. The washes were collected, and the semisynthetic enzyme was
concentrated, and buffer exchanged into buffer C [1 M NH4SO3, 50 mM Tris pH 7.5] via
ultrafiltration (Amicon Ultracel 30 kDa cut off filters). The concentrated enzymes were
then loaded by gravity onto a pre-equilibrated phenyl sepharose column (20 mL).
Following washing of column with buffer C, the semisynthetic mTrxR enzyme was
eluted from column with buffer lacking NH4SO3 [50 mM Tris pH 7.5]. This will disrupt
binding to the column. Fractions containing semisynthetic mTrxR were confirmed
41

spectrophotometrically by monitoring absorbance at 280nm and SDS-PAGE. The
samples containing enzyme were pooled and then buffer exchanged via ultrafiltration
with storage buffer [50 mM potassium phosphate, 500 mM NaCl, and 1 mM EDTA (pH
8.0)]. Concentration of the enzymes was determined through spectral analysis via the
absorbance maximum of the flavin at 460 nm ( = 22.6 mM-1cm-1, representing the
dimer).
Detection of Oxidative Modifications
mTrxR2 or DmTrxR at a concentration of 50 nm were incubated with 200 uM
NADPH, 1mM ethylenediaminetetraacetic acid (EDTA), and 50 mM ammonium
bicarbonate for 5mins while being shaken slowly. The reaction volume was 500 µl. After
5vmins 1 mM H2O2 was added and the reaction proceeded for 20 mins. Following the
incubation period 166 nM catalase was added and incubated for 5 mins. Samples were
then assayed with 90 µM selenocystine and activity was determined
spectrophotometrically by following the consumption of NADPH at 340 nm. Samples
were then treated with 10 mM iodoacetamide (IAA). IAA reacted with the samples for 20
mins in the dark at room temp while being slowly shaken. Following the 20 min
incubation samples were freeze dried. The samples were then resuspended in 95 µl of 50
mM ammonium bicarbonate pH 7.0. and 5 µl of a 0.2 µg/µl solution of trypsin was then
added. Samples were then incubated overnight at 37°C. All samples were then
concentrated under vacuum and resuspended in a 0.1% trifluoracetic acid/water solution
to a concentration of approximately 1.5 pg/µl. Samples were then analyzed via LC-MS.
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Inactivation of Truncated Enzymes
mTrxRΔ3 or truncated DmTrxRΔ3 were incubated at a concentration of 50 nM
with 200 uM NADPH, 1 mM EDTA, and 100 mM potassium phosphate in a final
reaction volume of 500 µl for 5 mins while being shaken slowly. After 5 mins 50 mM
H2O2 was added and the reaction proceeded for 20 mins. Following the incubation period
166 nM catalase was added and incubated for 5mins. After the incubation period 90 uM
DTNB was then added and DTNB reductase activity of the enzyme was determined
spectrophotometrically by measuring the change in absorbance at 412 nm. Truncated
enzymes were assayed with DTNB as these enzymes are capable of reducing this
substrate.
Hypobromous Acid Inactivation of TrxR
mTrxR2, mTrxR-GUUG, or mTrxR-GUCG at a concentration of 100 nM enzyme
were incubated with 200 uM NADPH, 1 mM EDTA, and 100 mM potassium phosphate
pH 7.0 in a final volume of 500 µl for 5 mins while being shaken slowly. After 5 mins
HOBr was added and the reaction proceeded for 20 mins. Following the incubation
period an equivalent (to HOBr) amount of cysteine was added and incubated for 5 mins.
This was done as any excess HOBr will react with cysteine. This will result in cystine
which is not a good substrate for the enzymes used in this experiment. Next, peroxidase
activity was determined by adding 10 mM H2O2 then measuring NADPH consumption
spectrophotometrically at 340 nm. H2O2 was chosen as a substrate as all enzymes used in
this experiment have substantial peroxidase activity. Because H2O2 was chosen as a
substrate HOBr was chosen as the oxidant.
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Inactivation of Insertion Enzymes
mTrxR2, mTrxR-GCAUG, or mTrxR-GCAAUG were incubated at a
concentration of 50nM with 200 uM NADPH, 1 mM EDTA, and 100 mM potassium
phosphate pH 7.0 for 5 mins while being shaken slowly. The reaction volume was 500 µl.
After 5 mins 10 or 50 mM H2O2 was added and the reaction proceeded for 20 mins.
Following the incubation period 166 nM catalase was added and incubated for 5 mins. 90
uM Trx was then added and thioredoxin reductase activity was determined by measuring
NADPH consumption at 340 nM spectrophotometrically. Trx was chosen as the substrate
as it is the canonical substrate of TrxR and all enzymes in this experiment have
significant Trx reductase activity.
Hydrogen Peroxide inactivation of TrxR
mTrxR2, mTrxR2-GGUG, DmTrxR, or DmTrxR-GGC were at a concentration of
50 nM were incubated with 200 uM NADPH, 1 mM EDTA, and 100 mM potassium
phosphate pH 7.0 in a total volume of 500 µl for 5 mins while being shaken slowly. After
5 mins H2O2 was added and the reaction was incubated for 20 mins. Following the
incubation period 166 nM catalase was added and incubated for 5 mins. 90 uM
selenocystine was then added and selenocystine reductase activity was determined by
measuring NADPH consumption at 340 nM spectrophotometrically. Selenocystine was
chosen as the substrate as all enzymes used in this experiment will readily reduce
selenocystine.
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Results
Purposed model of Resistance
We hypothesis that the ability of Sec to impart resistance to oxidative inactivation
in TrxRs is due to the greater electrophilicity of Sec relative to Cys. We believe this
allows the adjacent Cys residue in the motif GCUG to more readily attack and resolve
oxidation of the Sec residue. This Cys residue is known to be involved in the resolution
of the intermolecular selenosulfide that forms during the reduction of Trx (128).
Resolution by the adjacent Cys would prevent overoxidation of the Sec residue and allow
the enzyme to remain active. Our purposed model can be found in Figure 7.
Resolution of Oxidation by Adjacent Cys Residue
To determine the role of the adjacent Cys residue in resolution of oxidation we
generated mutant mTrxR2 enzymes in which one or two alanine residues were insert
between the Cys and Sec residues of the C-terminal redox site. We hypothesized that if
the Cys residue is involved in resolution of oxidation, by increasing the distance between
the two residues the rate of resolution would decrease. This would result in a decrease in
resistance to oxidative inactivation (Figure 8). However, after treating these enzymes
with H2O2 and measuring the remaining thioredoxin reductase activity, there was no
difference in the ability of these enzymes to resist oxidative inactivation (Figure 9).
To further investigate the role that the adjacent Cys residue plays is oxidative
resistance we generate mutant mTrxR2 and DmTrxR enzymes in which the Cys residue
was replaced with a glycine residue; mTrxR2-GGUG and DmTrxR-GGC respecitively.
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As glycine chemically inactive, we believed that if the Cys residue is involved in
resolution of oxidation, both TrxR mutants would be especially susceptible to oxidative
inactivation. Following exposure to H2O2, mTrxR2 and the corresponding resolving
mutant were assayed for selenocystine reducatse activity. We found that the resolving
mutant, at all concentrations of oxidant, had less activity then WT mTrxR2 (Figure 10a).
When DmTrxR and its resolving mutant were exposed to oxidant, the resolving mutant
also has less selenocystine reductase activity at all concentrations of oxidant (Figure
10b). Interestingly the resolving mutant of mTrxR2 had less selenocystine reductase
activity then the resolving mutant of DmTrxR at the highest concentration of H2O2
(Figure 10a and b).
Switching Positions of Cys and Sec in mTrxR2
The ability of Sec in mTrxR to act as a nucleophile has been well established
(130, 129, 131). Interestingly, the Cys orthologue DmTrxR which has a Cys residue in
place of Sec has been shown to be far more susceptible to oxidative inactivation (77).
Based on these findings we generated enzymes in which the positions of the Sec and Cys
residues in mTrxR2 (mTrxR-GCUG) are switched so that the penultimate residue
becomes Cys with the antepenultimate residue becoming Sec (mTrxR-GUCG). We also
made an enzyme in which we replaced the Cys residue with a Sec residue (mTrxRGUUG). It was hypothesized that due to the role of Sec in mTrxR2 to act as a nucleophile
and attack substrate, by replacing it with Cys, which is more susceptible to over oxidation
(77), the ability of mTrxR-GUCG to resist oxidative inactivation would be significantly
reduced. We hypothesized that the ability of mTrxR-GUUG to resist oxidative
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inactivation would be comparable to the WT enzyme (mTrxR-GCUG). Following
exposure to either 50 or 100µM HOBr, enzymes were assayed with H2O2 and their
peroxidase activity measured (Figure 11). It was observed both the WT enzyme and
mTrxR-GUUG had comparable levels of retained peroxidase activity at all concentrations
of oxidant (Figure 11a and c). However, mTrxR-GUCG was much more susceptible to
oxidative inactivation (Figure 11c).
Inactivation of Truncated Enzymes
TrxR enzymes contain both a C-terminal redox site and an N-terminal redox. The
N-terminal redox site is composed of the conserved motif CVNVGC. It is known this
domain is accessible in both mTrxR2 and DmTrxR and is capable of reducing several
small molecule substrates such as DTNB and lipoamide (132, 133, 134, 135, 67).
Interestingly the N-terminal redox site of cytosolic mammalian thioredoxin reductase
(mTrxR1) is not as accessible as mTrxR2 owing to structural differences between
mTrxR1 and mTrxR2 (34). These structural differences result in the enzyme being very
dependent on Sec to turnover small molecule substrates (96). As the N-terminal redox
site of the enzyme we investigated in this study, mTrxR2, has an accessible N-terminal
redox site whose catalytic residues are Cys, we wanted to determine to what extent overoxidation of these residues contribute to the inactivation of mTrxR2 and DmTrxR. To
determine this mTrxR2 and DmTrxR enzymes missing the final 3 amino acids, CUG for
mTrxR2 and CCS for DmTrxR were constructed; mTrxRΔ3 and DmTrxRΔ3. After
exposure to 50 mM H2O2 it was determined that mTrxRΔ3 enzyme lost very little DTNB
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reductase activity (Figure 12a & c). The truncated DmTrxRΔ3 enzyme also lost very
little activity (Figure 12b & c).
Detection of Oxidative Modifications
Our current and previous work (77) has demonstrated that Sec TrxRs resist
oxidative inactivation better then Cys TrxRs. To determine what types of oxidative
modifications are responsible for enzyme inactivation we treated mTrxR2 and DmTrxR
with 1mM H2O2 and analyzed the samples using LC-MS. It was found that there was no
difference in the oxidation states of the N-terminal or C-terminal of domains of mTrxR2
with both being alkylated (Figure 13). It was also discovered that there was no difference
between the oxidation states of the N-terminal redox site of control or oxidant treated
DmTrxR (Figure 14). Interestingly there was a difference between the oxidation states of
the C-terminal redox site of the control and oxidant treated DmTrxR. There was an 67%
increase in the amount of C-terminal peptide that was found to have both Cys residues
modified to DHA.

Discussion
Method of Resistance. We have previously shown that enzymes containing Sec
resist overoxidation following exposure to various oxidants (77). Here we wanted to
investigate how TR resists overoxidation. We hypothesized that the primary difference in
the ability of Sec-TR to resist overoxidation is due to the greater electrophilicity of the
selenenic acid compared to the sulfenic acid intermediates that are formed following the
initial oxidation of Sec or Cys respectively. The greater electrophilicity of selenenic acid
48

would allow the adjacent Cys to resolve oxidation quicker and prevent further oxidation
(Figure 7). Our MS data provides support for this theory as there was no difference in the
detected oxidative modifications of mTrxR2 enzymes treated with oxidant and nonoxidized controls (Figure 13). However, DmTrxR enzymes treated with oxidant showed
increases in DHA on both C-terminal Cys residues (Figure 14). These modifications are
irreversible and serve as an indication as to how DmTrxR inactivates following treatment
with oxidant. Based on these results we attempted to disrupt the ability of the adjacent
Cys residue to resolve oxidation of Sec in mTrxR2. We did this by increasing the
distance between these residues by inserting alanine residues in between them (Figure 8).
Interestingly when we increased the distance, there was little difference in the ability of
mTrxR2 or the insertion mutants to resist overoxidation (Figure 9). The C-terminal tail
of thioredoxin is inherently flexible. This flexibility may allow for the of the C-terminal
resolving Cys to still attack the selenenic acid and prevent overoxidation in the insertion
mutants. To further investigate the role of the adjacent Cys we created mTrxR2 and
DmTrxR mutants in which the adjacent Cys residue was mutated to glycine (Figure 10a
and b). We hypothesized that if the Cys residue was not involved in resolution of
oxidation then these mutants would not differ in their ability to resist oxidative
inactivation relative to the WT enzymes. The resolving mutants for both mTrxR2 and
DmTrxR both showed increased susceptibility to oxidative inactivation (Figure 10).
However, the mTrxR2 resolving enzyme showed far greater sensitivity to loss of the
adjacent Cys residue then DmTrxR. This is obvious when comparing the retained activity
of the resolution mutants with the mutant of mTrxR2 almost being completely inactivated
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at 50 mM H2O2 and the resolving mutant of DmTrxR retaining ~30% of its activity. This
is most likely due to a difference in reactivity between the Sec and Cys. Selenium is a
better nucleophile than sulfur and at a pH of 7.0, the pH at which the experiments were
carried out, almost of all Sec residues would be in the active selenolate form (50). These
properties would lead the resolving mutant mTrxR2 to readily become over oxidized
whereas the resolving mutant DmTrxR is less reactive and would be less likely to become
inactivated. The results of these experiments provide very strong evidence for our
hypothesis that the adjacent Cys plays a role in the ability of TrxR to resist over
oxidation. This residue is already known to play a role in the reduction of Trx (128) so it
would be likely that it would function in a similar manner during resolution of oxidation.
Our results demonstrate that mTrxR2 retains more activity than DmTrxR
following treatment with oxidant and are in agreement with our previous findings (77).
This difference is most likely due to the faster resolution of selenenic acid by mTrxR2
relative to the resolution of sulfenic acid by DmTrxR. However, there is evidence that
TrxR may be able to utilize higher oxidation states of selenium (84). To investigate this,
we treated mTrxR2 with 1 mM H2O2 and dimedone. As we have reported dimedone will
react with seleninic acid to form a dimer which is detectable via MS (136). We were
unable to detect any dimer (data not shown). This maybe due to mTrxR2 rapidly reducing
selenenic acid and preventing further oxidation, however more research needs to be done
to determine if Sec TrxRs can indeed use higher oxidation states.
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Switching Positions of Cys and Sec in mTrxR2.
As we have discussed throughout this study, we believe the ability of Sec TrxR to
resist oxidative inactivation is dependent upon the electrophilic character of selenenic
acid. To provide further evidence in support of this hypothesis we made a mutant enzyme
in which the positions of the Sec and Cys residues of mTrxR2 were switched resulting in
an enzyme with the C-terminal sequence being GUCG. Additionally, we created a mutant
in which the resolving Cys residue was mutated to Sec, mTrxR-GUUG. As it has been
established that the penultimate position is involved in nucleophilic attack of substrate
(138, 130, 96, 129), we hypothesized that mTrxR-GUCG would be more susceptible to
oxidative inactivation while mTrxR-GUUG would have a similar level of resistance to
over oxidation as the WT mTrxR2. Our results show that both mTrxR2 and mTrxRGUUG had similar levels of resistance to treatment with HOBr (Figure 11). This is most
likely due to the formation selenenic acid at the penultimate residue in both enzymes.
Selenenic acid should then be quickly resolved by the adjacent residue. However, as we
hypothesized, mTrxR-GUCG was far less resistant to oxidation then WT mTrxR2
(Figure 11). This decrease in resistance is most likely due to the formation of the less
electrophilic sulfenic acid which should not be readily resolved and would undergo
further oxidation resulting in enzyme inactivation.
Inactivation of Truncated TrxR.
Because TrxRs contain both an N-terminal and C-terminal redox site we
generated mutant enzymes of mTrxR2 and DmTrxR that were missing the last three
amino acids. This would render the redox site inactive as it would be missing the
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chemically active residues. We discovered that upon treatment with oxidant these
enzymes lost little activity (Figure 12). This result is also supported by our MS data
which shows no difference in the oxidation states of the N-terminal redox sites of
enzymes treated with oxidant compared to controls in which the enzymes were not
treated with oxidant (Figure 13 and 14). This is most likely due to the inability of H2O2
to access the N-terminal redox Cys residues. These results also provide evidence in
support of our purposed model of resistance as the N-terminal redox site does not appear
to be sensitive to oxidant.

Conclusion
In this study we have investigated the mechanism by which TrxRs resist over oxidation.
We have provided evidence that Sec TrxRs can rapidly reduce the selenenic acid that
forms in the C-terminal redox site upon exposure to oxidant. This allows the enzyme to
prevent over-oxidation. We have also provided evidence that Cys TrxRs, such as
DmTrxR, cannot readily reduce the sulfenic acid that forms in the C-terminal redox site
upon exposure to oxidant. This results in overoxidation and enzyme inactivation. The
ability of selenenic acid to be more rapidly reduced then the sulfenic acid is due to its
greater electrophilicity. These results along with our groups previous work (77)
demonstrate that one benefit that Sec imparts to proteins is the ability to resist
overoxidation.
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Figure 7.

Figure 7. Purposed model TrxR resistance to over oxidation. We hypothesis that the increase
electrophilicity of selenenic acid allows for quick resolution by the adjacent Cys residue in
mTrxR2. This allows the enzyme to be protected from over oxidation. Whereas the sulfenic acid
intermediate is less nucleophilic and will not be resolved as fast. This would result in a greater
chance at over oxidation and inactivation.
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Figure 8.

Figure 8. Alanine insertion mutants of mTrxR2. One or two alanine residues (orange) were
inserted in between the Cys and Sec residues. We hypothesized that by increasing the distance
between those residues would decrease the resistance of the mTR to over oxidation.
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Figure 9.

Figure 9. Remaining Trx reductase activity of mTrxR2, single insertion mutant (GCAUG), and
double insertion mutant (GCAAUG). Panel 1 are plots (A340 vs time) of the Trx activity of (a)
mTrxR2, (b) single insertion mutant, and (c) double insertion mutant. Each trace is representative
of a single experiment. Black traces represent control (no oxidant) experiments while blue traces
represent 50 mM H2O2 treatments. Panel 2 displays the quantified Trx activity of (a) mTrxR2, (b)
GCAUG, and (c) GCAAUG. Each bar is the average of 3 experiments with activity displayed as a
percentage of the control experiment (no oxidant). Error bars display standard deviation of each
set of experiments.

55

Figure 10.

Figure 10. TrxR resolution mutants. (a) mTrxR2 and (b) DmTrxR resolution mutants. Assay data
is displayed as % selenocystine reductase activity remaining following exposure to 10 mM or 50
mM H2O2 relative to the control. Each bar represents the average of 3 experiments. Error bars
display standard deviation of each individual set of experiments. The structures below are
representative of the C-terminal redox site of the resolving mutants of mTrxR2 (a) or DmTrxR
(b).
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Figure 11.

Figure 11. Remaining peroxidase activity of (a) mTrxR2, (b) mTrxR-GUCG, and (c) mTrxRGUUG following exposure to 50 or 100 µM HOBr as compared as compared to the no oxidant
controls. The data displayed is the average of those three experiments. Standard deviation of the
experiments is represented by the error bars. The structures below the panels represent the Cterminal redox site of mTrxR2 (a), mTrxR-GUCG (b), and mTrxR-GUUG (c).
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Figure 12.

Figure 12. Remaining DTNB reductase activity of (a) mTrxRΔ3 and (b) DmTrxRΔ3 following
exposure to 50 mM H2O2. Panels a and b are plots (A412 vs time) of the DTNB reductase activity
of representative expereiments. Black traces represent control (no oxidant) experiment. The red
trace in panel a represents oxidant treated mTrxRΔ3 while blue trace in panel b represents oxidant
treated DmTrxRΔ3. Panel c displays the average DTNB reductase activity of three experiments
with activity displayed as a percentage of the control experiment (no oxidant). Error bars display
standard deviation of each set of experiments.

58

Figure 13.
Redox Site

Modification

WGGTCVNVGCIPK
SGLEPTVTGCUG

WGGTC(Carb)VNVGC(Carb)IPK
SGLEPTVTGC(Carb)U(Carb)G

% Change Relative to
Control
0%
0%

Figure 13. Analysis of oxidative modifications of mTrxR2. Samples were treated with 1mM
H2O2 and assayed for retained selenocystine reductase activity (a). Samples were then analyzed
for oxidative modifications via MS. The sequences and modifications of the N-terminal
(WGGTCVNVGCIPK) and C-terminal (SGLEPTVTGCUG) redox sites of the oxidant treated
samples are displayed. The difference in relative abundance of the detected modifications
compared to the control are also displayed (b). Detected modifications are found within the
parenthesis with the detected chemical modifications abbreviated. Abbreviations refer to the
following modifications; Carb carbamidomethylation.
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Figure 14.
Redox Site

Modification

WGVGGTCVNVGCIPKKL
SGLDPTPASCCS

WGVGGTC(Carb)VNVGC(Carb)IPKKL
SGLDPTPASC(DHA)C(DHA)S

% Change
relative to
Control
0%
67%

Figure 14. Analysis of oxidative modifications of DmTrxR. Samples treated with 1mM H2O2
were assayed for retained selenocystine reductase activity (a). MS was then used to detect any
oxidative modifications. N-terminal (WGVGGTCVNVGCIPKKL) and C-terminal
(SGLDPTPASCCS) redox sequences and detected modifications of the oxidant treated samples
are displayed. The difference in relative abundance of the detected modifications compared to the
control are also displayed (b). Detected modifications are found within the parenthesis in the table
with the detected chemical modifications abbreviated. Abbreviations refer to the following
modifcations; Carb carbamidomethylation, DHA dehydroalanine, SO3 sulfonic acid.
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Chapter 3:
Detection of Sec Oxidation States with
Dimedone

Figure 15. Dimedone is a common alkylating agent that is used to label sulfenic acid. No
work has been done on its ability to react with various selenium oxidation states. In this
chapter I will discuss our investigation of the reactivity of dimedone toward selenenic
acid and seleninic acid.
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Here we investigate the reactivity of dimedone toward selenenic acid and
seleninic acid. Dimedone is a widely used reagent to assess the redox state of cysteinecontaining proteins as it will alkylate sulfenic acid residues, but not sulfinic acid residues.
While it has been reported previously that dimedone can label selenenic acid residues in
selenoproteins, we investigated the stability, and reversibility of this label in a model
peptide system. We also wondered whether dimedone could be used to detect seleninic
acid residues due to the much stronger electrophilic character of selenium relative to
sulfur. We used model chemical compounds, benzenesulfinic acid, benzeneselenenic
acid, and model selenocysteine-containing peptides to investigate possible reactions with
dimedone.
Use of Dimedone to Detect Sec
Dimedone (5,5-dimethylcyclohexane-1,3-dione), a small molecule 1,3-diketone,
is frequently used to detect protein sulfenic acids, as dimedone will alkylate Cys-sulfenic
acids forming a stable adduct that can be detected by mass spectrometry (137). It has also
found use in labeling Sec-selenenic acids of selenoproteins (138, 139). However, in the
case of selenoprotein S, the selenenic acid could only be alkylated when a resolving Cys
residue was mutated to serine (Ser), otherwise rapid formation of a selenosulfide bond
prevented alkylation of the selenenic acid with dimedone (138).
mTrxR is a selenoenzyme whose primary catalytic function is to reduce the
oxidized form of Trx, a small dithiol-containing protein that serves to maintain cellular
redox homeostasis (140). The enzyme also has weak peroxidase activity due to the
presence of Sec as discussed above (96). Presumably, this peroxidase activity is due to
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the reaction of the Sec-selenolate with H2O2 to form a Sec-selenenic acid, which can then
be resolved by an adjacent Cys residue to form a selenosulfide bond as shown in Figure
16A. If the lifetime of the Sec-selenenic acid is long enough it could theoretically be
alkylated by dimedone (Figure 16B), causing inhibition of the enzyme. Similar to the
study done with selenoprotein S, we also were unable to use dimedone to alkylate the
selenenic acid of wild type mTrxR as shown by the absence of inhibition of the enzyme
in the presence of dimedone (138, 84).
As in the case of selenoprotein S, the lack of alkylation by dimedone could be due
to rapid resolution of the Sec-selenenic acid by the adjacent, resolving Cys residue
(Figure 17A), but other possibilities exist as well. These other possibilities are: (i) the
Sec-selenenic acid is alkylated by dimedone, but the alkylation is rapidly reversed by the
resolving Cys residue (Figure 17B), and (ii) the Sec residue is over oxidized to a Secseleninic acid (Sec-SeO2–) (Figure 17C). If the reactivity of Sec-seleninic acid is
identical to Cys-sulfinic acid, then it is expected that dimedone would be unreactive
towards Sec-seleninic acid and alkylation would not occur. However, the reactivity of
seleninic acid with dimedone is heretofore unknown
In this study, we explored these three options by studying the reaction of
dimedone with model peptides that correspond to the C-terminal tail of mTrxR, which
contains the Sec residue. We found that the peptide H-PTVTGCUG-OH, containing the
adjacent, resolving Cys residue, could not be alkylated with dimedone. We were, on the
other hand, able to alkylate a “mutant” peptide (H-PTVTGAUG-OH) with dimedone in
which the resolving Cys residue was replaced with alanine (Ala). However, this
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alkylation could be reversed by addition of reducing agents such as ΒMe and TCEP.
Surprisingly, dimedone alkylation could also be reversed by adding disulfides such as
hydroxyethyldisulfide (HED) and cystine to the alkylated peptide. The diselenidecontaining compound selenocystine also reversed dimedone alkylation. An important
finding of this study is that dimedone reacts with Sec-seleninic acid, unlike the
corresponding reaction of dimedone and Cys-sulfinic acid. Reaction of dimedone with
model seleninic acids resulted in formation of diselenides and a dimedone dimer as a
result of a seleno-Pummerer reaction (142,143,144,145). We were able to detect this
dimeric form of dimedone when higher concentrations of H2O2 were used to oxidize the
mutant peptide, H-PTVTGAUG-OH, in the presence of dimedone. This result may lead
to the development of a method to detect Sec-seleninic acid, a highly transient species, in
selenoproteins.
METHODS
General methods
Unless otherwise stated, all non-aqueous reactions were carried out in either ovendried or flame-dried glassware. All commercially available starting materials were
purchased from Aldrich, Fischer Scientific, or Acros Organics, and used as received.
Analytical thin-layer chromatography (TLC) was performed on Millipore TLC Silica gel
60 F254 silica gel plates with UV indicator. Visualization was accomplished by irradiation
under a 254 nm UV lamp or stained with either an aqueous solution of ceric ammonium
molybdate, potassium permanganate, or phosphomolybdic acid. Flash chromatography
was performed using a forced flow of the indicated solvent system on silica gel (32-63
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mesh). Removal of solvents was accomplished on a Büchi R-114 rotary evaporator and
compounds were further dried under a high vacuum line.
All 1H NMR data was conducted at ambient temperatures and recorded on a
Varian Unity Inova (500 MHz) or Bruker ARX (500 MHz) spectrometer. 13C and 77Se
NMR spectra were recorded on a Bruker ARX spectrometer (125 MHz and 95 MHz,
respectively). Chemical shifts for 1H NMR and 13C NMR are reported in parts per million
(ppm) at 25 °C relative to chloroform or methanol (δ = 7.26 ppm or 3.31 ppm for 1H
NMR; δ = 77.16 ppm or 49.00 ppm for 13C NMR, respectively). Data are reported as
follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, p =
pentet, br = broad, m = multiplet), coupling constants (Hz), and number of protons.
Direct infusion mass spectrometry was executed using an ABI Sciex 4000QTrap Pro
LCMS in positive-ESI or APCI mode. Liquid chromatography-mass spectrometry
(LCMS) was executed using an ABI Sciex 4000QTrap Pro LCMS equipped with a C18
column in positive-ESI mode.
All analytical HPLC chromatography was carried out on a Shimadzu analytical
HPLC system which utilized LC-10AD pumps, a SPD-10A UV-Vis detector, and a SCL10A controller. A Shimadzu Shim-pack™ VP-ODS C18 analytical column (4.6 μm pore
size, 150 × 4.6 mm) was used in these separations. Beginning with 100% Buffer A, a 1.4
mL/min gradient elution increase of 1% Buffer B/min for 50 min was used for all peptide
chromatograms (Buffer A = 0.1% TFA/H2O; Buffer B = 0.1% TFA/ACN). Peptide
elution profiles were detected at 214 nm and 254 nm.
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Production of thioredoxin reductase by semisynthesis
The wild type mTrxR-GCUGe enzyme and the mutant mTrxR-GGUG enzyme
were produced by protein semisynthesis using well described methods published by our
laboratory (132).
Attempt to inhibit thioredoxin reductase by dimedone treatment in presence of H2O2
Wild type mTrxR-GCUG (10 nM) or mutant mTrxR-GGUG (50 nM), were
incubated with 200 μM NADPH and 1 mM EDTA in 100 mM potassium phosphate
buffer, pH 7.0 for 5 min. After 5 min, 500 μM dimedone or the same volume of methanol
(control) was added to the reaction mixture along with 300 μM H2O2. The reactions were
incubated for 25 min followed by the addition of catalase (170 nM) for 5 min to quench
the H2O2. Enzyme activity was then initiated by the addition of 90 μM selenocystine, and
enzyme activity was determined spectrophotometrically by following the consumption of
NADPH at 340 nm.
Peptide Synthesis
Peptides were synthesized as previously described using 2-chlorotritylchloride
resin and standard Fmoc-solid phase peptide synthesis protocol (132). Once synthesized,
peptides were cleaved from the resin using a cocktail containing 96:2:2 TFA, TIS, H2O,
and 2 equivalents of DTNP (146, 147). Following cleavage, the volume was reduced by
evaporation under a stream of N2 and peptide was precipitated using cold Et2O. Once dry,
the peptides were suspended in H2O with minimal acetonitrile, frozen (-78 °C),
lyophilized, and purified via preparatory HPLC. Peptide composition was analyzed using
direct infusion APCI mass spectrometry.
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Labeling of model Sec-containing peptides with dimedone
Peptides were synthesized with the Sec residue initially protected as the pmethoxybenzyl (Mob) derivative. The Mob group on Sec was replaced with a 5-nitro-2pyridinesulfenyl (5-Npys) group by addition of DTNP to the cleavage cocktail (146).
Upon addition of DTNP, the Mob protecting group on Sec is replaced with 5-Npys.
Attack by the adjacent Cys residue of the wild type peptide (H-PTVTGCUG-OH) onto
the selenium atom of the Sec(5-Npys) group results in the rapid formation of an
intramolecular selenosulfide bond.
The oxidized, wild type peptide (5 M) was reduced with 50 M TCEP in 100
mM potassium phosphate pH 7.0 for 15 min, followed by incubation with 50 M or 500
M dimedone and 5 M H2O2 at room temperature while being shaken at low speed for
25 min. The samples were then analyzed via LCMS.
As a control, the same peptide (5 M) was reduced with 50 M TCEP in 100 mM
potassium phosphate buffer, pH 7.0 for 15 min. After, 10 mM iodoacetic acid was added
and the reaction was shaken in the dark at room temperature for 25 min. The samples
were then analyzed via LCMS.
In the mutant peptide, H-PTVTGAUG-OH, the Sec residue was protected as
Sec(5-Npys), and in this form is less reactive towards oxidation. In order to generate a
free selenol in situ, the 5-Npys protecting group was removed by addition of ascorbate in
100 mM potassium phosphate pH 7.0 for 30 min at 37 °C as we have previously reported
(148). The ratio of ascorbate to peptide (0.9:1) was sub-stoichiometric to ensure that no
ascorbate remained after deprotection that could potentially scavenge H2O2 or reduce
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oxidized Sec species during the experiment. Following deprotection, the peptide (5 M)
was incubated with 50 M dimedone and 5 M H2O2 at room temperature while being
shaken at low speed for 25 min. The reactions were then analyzed using LCMS as
described above.
Demonstrating the lability of the Sec-dimedone label
Peptides were labeled with dimedone as described above. Following the 25 min
incubation with 50 M dimedone and 5 M H2O2, ΒMe, 10x, TCEP (10x), cystine
(1000x), or selenocystine (1000x) were added to the reaction mixture. The reactions were
incubated at room temperature for 15 min while being shaken at low speed then analyzed
via LCMS.
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Se NMR time course of reactions between dimedone and seleninic acids
A concentrated solution (~150 mM) of benzeneseleninic acid (PhSeO2H) or

methaneseleninic acid (MeSeO2H) in CD3OD was made and an initial 77Se NMR
spectrum was taken as the initial time point. After, the solution was diluted at room
temperature with a stock solution of dimedone in CD3OD so that the final concentration
of PhSeO2H or MeSeO2H was 100 mM and the concentration of dimedone was 200 mM.
The solution was immediately inserted into the spectrometer and 77Se NMR spectra were
taken every 3 h for 6 h (PhSeO2H) or every 15 min for 30 min (MeSeO2H).
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LCMS analysis of reaction between dimedone and PhSeO2H
A 10 mL solution of 100 mM PhSeO2H and 200 mM dimedone in CH3OH was
made and the reaction was allowed to proceed with stirring for 48 h at room temperature.
An aliquot of the reaction mixture was taken and analyzed via LCMS as described above.
2.9. Attempt to purify dimedone byproducts of reaction between dimedone and PhSeO2H
Dimedone (280.4 mg, 2 mmol) was dissolved in methanol (10 mL) and
benzeneseleninic acid (189.1 mg, 1 mmol) was added. The reaction was stirred at room
temperature for 48 hours. The solvent was evaporated and the crude mixture was
purified via flash chromatography (SiO2; 4:1 ethyl acetate/dichloromethane) to yield 2 as
a white, crystalline solid, which was the only product able to be isolated.
1

H NMR (500 MHz, chloroform-d) δ 2.28 (s, 4H), 2.22 (s, 4H), 1.63 (s, 6H), 1.06 (s,

12H). 13C NMR (125 MHz, chloroform-d) δ 197.64, 160.58, 119.81, 53.04, 41.54, 32.16,
31.63, 28.19, 26.05. MS (pos ESI) m/z 303.4 [(M + H)+, calculated for C19H26O3:
302.41]. Anal. Calcd. for C19H26O3: C, 75.46; H, 8.67. Found: C, 74.79; H, 8.67.
Formation and detection of dimeric dimedone species (1a) upon reaction of mutant
peptide and H2O2.
The 5-Npys protecting group of H-PTVTGAU(5-Npys)G-OH (1 mM) was
removed by incubation with ascorbate at a ratio of 0.9:1 ascorbate:peptide in 100 mM
potassium phosphate pH 7.0 for 30 min at 37 °C as described above. Following
deprotection, the peptide was incubated with 2 mM dimedone and 5 mM H2O2 for 25 min
at room temperature while being shaken at low speed, after which the samples were
analyzed via LCMS.
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RESULTS
Attempt to inhibit thioredoxin reductase by dimedone treatment in presence of H2O2
To address the question of whether the adjacent Cys residue of mTrxR-GCUG
interferes with alkylation of Sec-selenenic acid by dimedone, we constructed a mutant
enzyme in which the adjacent Cys residue was replaced by Gly (mTrxR-GGUG). Both
the wild type enzyme, mTrxR-GCUG, and mutant enzyme, mTrxR-GGUG, were
subjected to a selenocystine reductase assay, which measures each enzyme’s ability to
reduce selenocystine after exposure to H2O2 and dimedone (149). In this assay, the %
selenocystine reductase activity remaining of each enzyme after exposure to H2O2 and
dimedone is indicative of how much Sec-selenenic acid is being alkylated by dimedone.
The results from this experiment are shown in Table 2. The data show that the wild type
mTrxR-GCUG enzyme retained full selenocystine reductase activity, which is identical
to our previous result (84). However, the mutant mTrxR-GGUG enzyme retained only
74% of selenocystine reductase activity after being exposed to H2O2 and dimedone. We
interpret this result as the Sec-selenenic acid of the mutant enzyme mTrxR-GGUG being
alkylated with dimedone, causing inhibition of selenocystine reductase activity. In this
case, the Sec-selenenic acid of the mutant enzyme could be alkylated because there was
no resolution of Sec-selenenic acid by the adjacent Cys residue. We believe the reason
for the lack of complete inhibition of the mutant enzyme by dimedone is due to the
presence of the N-terminal redox center of the enzyme, which contains two Cys residues
that may be able to reverse the alkylation.
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Labeling of model Sec-containing peptides with dimedone
The peptides that we chose to synthesize were based on the C-terminal amino acid
sequence of mTrxR. We either synthesized the wild type peptide, H-PTVTGCUG-OH, or
mutant peptide, H-PTVTGAUG-OH. In the case of the mutant peptide, the
antepenultimate Cys residue has been mutated to Ala to avoid resolution of Sec-selenenic
acid, as would occur if the adjacent Cys was present in the peptide, resulting in the
formation of a selenosulfide bond (Figure 16A).
First, we performed a control experiment with the oxidized, wild type peptide. We
reduced the wild type peptide with a 10-fold excess of TCEP and the alkylated it with
iodoacetic acid. The results showed that both the Cys and Sec residue of the peptide
could be carboxymethylated (Figure 18). However, in a similar experiment, we were
unable to alkylate the wild type peptide with either 50 mM dimedone (10-fold excess) or
500 mM dimedone (100-fold excess) in the presence of H2O2, identical to our results with
the full-length enzyme (Figures 19 and 20). The fact that we were able to dialkylate the
peptide with iodoacetic acid shows that we were able to effectively reduce the
selenosulfide bond with TCEP, making both the sulfur and selenium susceptible to
oxidation by H2O2 and subsequent labeling by dimedone. The lack of dimedone
alkylation shows that it must be the specific Se–C bond of the Sec-dimedone adduct that
is labile for the reasons we discuss in Figure 17, as the carboxymethylation of Sec by
iodoacetic acid was not reversed by the resolving Cys residue.
A difficulty in our experimental design with the mutant peptide that had
to be overcome was the generation of free Sec-selenol. Alkyl selenols do not exist in
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solution for a long duration due to their tendency to oxidize to the diselenide form (150).
To mitigate this problem, we utilized a strategic protecting group, 5-Npys, on Sec, that
allowed us to rapidly generate Sec-selenol in situ, which could be further oxidized to Secselenenic acid by H2O2 and alkylated with dimedone as shown in Figure 21. The
selenosulfide bond between the selenium of Sec and the sulfur of the 5-Npys group is
readily cleaved by ascorbate, generating dehydroascorbic acid in the process (148).
Therefore, before oxidizing the Sec peptide in the presence of dimedone, the relevant
selenol form of Sec was generated by incubating the 5-Npys-protected Sec-peptide with
ascorbate. This approach does not depend on the use of an exogenous thiol to generate
the selenol. The presence of exogenous thiol would have greatly complicated the
interpretation of the results, as the added thiol could potentially reverse alkylation of Sec
by dimedone.
The results of our attempts to alkylate the Sec-selenenic acid of peptide H-PTVTGAUGOH with dimedone are displayed in Figure 22. The extracted ion chromatogram in
Figure 22A shows that the vast majority of peptide H-PTVTGAUG-OH is oxidized to
the Sec-selenenic acid and subsequently alkylated with dimedone. Peptide that was not
labeled was oxidized to the diselenide, which is the product of the disproportionation of
two selenenic acids (150). Thus, the 10-fold excess of dimedone relative to peptide used
in the experiment was sufficient for the alkylation reaction to outcompete
disproportionation. We note that, in both cases, the mass spectra shown in Figure 22B
and Figure 22C clearly display the characteristic isotope pattern of selenium-containing
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peptides, which dispels any doubt that the signal corresponding to the dimedonealkylated H-PTVTGAUG-OH is artifactual.
Demonstrating the lability of the Sec-dimedone label
After successfully alkylating the Sec-selenenic acid of peptide H-PTVTGAUGOH with dimedone, we desired to address the question raised in Figure 17B, that is,
could the reason the wild type form of mTrxR retains peroxidase activity even in the
presence of dimedone be due to the fact that the dimedone label is being removed by the
adjacent, resolving Cys residue? To address this question, we subjected mutant peptide
H-PTVTGAUG-OH to the same conditions used to alkylate the Sec-selenenic acid with
dimedone, then immediately incubated the alkylated peptide with 10-fold molar excesses
of βME or TCEP for 15 min. Figure 23 shows the results from these experiments, which
demonstrate that under reducing conditions, the Sec-dimedone label is labile. In the case
of βME, the dimedone label was removed and the peptide was detected as the βME
adduct. However, when TCEP was used as the reducing agent, the TCEP adduct was not
detected. When 1000x βME was used, no dimedone-labeled peptide H-PTVTGAUG-OH
was detected and only the βME adduct was observed (data not shown). For comparison,
experiments conducted by Carroll et. al. showed that the Cys-dimedone label of a model
dipeptide was stable over 12 h to similar reducing conditions of 10-fold molar excesses of
dithiothreitol (DTT), glutathione (GSH), or TCEP(151).
To further validate our experiment showing that addition of ΒMe results in
removal of the dimedone label, we did a control experiment in which hydroxyethyl
disulfide was added instead. To our surprise, addition of this disulfide also resulted in
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removal of the dimedone label (data not shown). We then repeated this experiment using
the more relevant disulfide compound cystine instead, and this disulfide also resulted in
removal of the dimedone label and formation of a cysteinyl-peptide adduct. We reasoned
that addition of a diselenide should enhance removal of the dimedone label, so
selenocystine was added as a removal agent. Indeed, we found that addition of the
diselenide enhanced the amount of dimedone label removed from the peptide (see the
bottom two panels of Figure 23).

Reaction of dimedone with model seleninic acids
The reactivity of dimedone towards seleninic acids has not been reported in the
literature so far as we are aware. While we showed that one possible reason mTrxR is not
inhibited by dimedone in the presence of H2O2 is due to the removal of the Sec-dimedone
adduct by thiols (Figure 17B), the question raised in Figure 17C still remained
unaddressed, could dimedone be reacting with a Sec-seleninic acid? We hypothesized
that dimedone would react with seleninic acids because of their high Se-electrophilicity.
Seleninic acids, unlike sulfinic acids, are highly electrophilic and can be rapidly reduced
by thiols and other reducing agents (50).
The reactivity of dimedone towards seleninic acids was first explored in a
qualitative, model experiment, where a solution of 100 mM PhSeO2H and 200 mM
dimedone was prepared in methanol. After approximately 15 min, the solution turned
from clear, colorless to an intense yellow color, indicating a reaction between the two
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compounds. The observation of this yellow color led us to hypothesize that one product
of the reaction could be diphenyl diselenide, which has a yellow color in solution.
In order to further test this hypothesis, we employed a 77Se NMR time course
experiment where the reaction between PhSeO2H and dimedone in CD3OD was followed
for 6 h in 3 h intervals. The results from this experiment are shown in Figure 24. As
shown in the figure, a resonance at δ = 463 ppm appeared within 3 h of reaction time and
remained the only observable resonance after 6 h. A control 77Se NMR spectrum of the
pure compound confirmed that this resonance corresponds to diphenyl diselenide, which
further supports our hypothesis that dimedone is indeed reducing PhSeO2H (+2 oxidation
state) to the diselenide form (-1 oxidation state).
Next, in order to show that dimedone would react not only with aromatic seleninic
acids, but also with alkyl seleninic acids such as Sec, we monitored the reaction of
commercially available MeSeO2H with dimedone in CD3OD using the same 77Se NMR
time course experiment. As shown in Figure 25, dimedone quantitatively reduces
MeSeO2H to dimethyl diselenide (δ = 263 ppm) after only 30 min of reaction time
As a control, the reactivity of dimedone towards benzenesulfinic acid (PhSO2H),
the sulfur-containing analog of PhSeO2H, was explored in a 1H NMR time course
experiment (Figure 26). As expected, there was no observable reaction between
dimedone and PhSO2H even after 7 days of reaction time. Furthermore, because the pKa
of PhSeO2H is 4.79, we conducted a control experiment designed to show that dimedone
was, in fact, undergoing a redox reaction with the model seleninic acids, and not just an
acid-base reaction (152). The reactivity of dimedone in acidic media generated by p76

toluenesulfonic acid (p-TsOH) was determined in a similar 1H NMR time course
experiment and after 24 h there was no observable change in the 1H NMR spectrum
(Figure 27), providing further evidence that dimedone is, indeed, participating in a redox
reaction with the model seleninic acids.
While the identities of the selenium-containing products of the reaction between
dimedone and either PhSeO2H or MeSeO2H were readily revealed by our 77Se NMR time
course experiments, the fate of dimedone in the redox reaction could not be determined
by 77Se NMR. In an attempt to determine the oxidation products of dimedone in its
reaction with seleninic acids, we conducted 1H NMR time course experiments monitoring
the reaction between either PhSeO2H or MeSeO2H, and dimedone in CD3OD (Data not
shown). However, these experiments did not aid in product identification because only
new alkyl 1H NMR resonances, slightly downfield of the original resonances, were
observed during the time course, and these resonances were not informative.
Despite this result, we hypothesized that the seleninic acids were undergoing a
variation of the Pummerer reaction, as shown in Figure 28 (142,143,144,145). This
hypothesis was based on the fact that the seleninic acid was being reduced to the diselenide,
which means that dimedone must be oxidized during the reaction. In the first step of the
proposed mechanism, the nucleophilic carbon atom of dimedone attacks the electrophilic
selenium atom of the seleninic acid with subsequent elimination of a molecule of water,
resulting in the formation of a selenoxide intermediate. After eliminating another molecule
of water, the electrophilic selenonium species is attacked by another molecule of dimedone
to produce a selenide. Last, elimination of selenolate anion (pKa ~ 5.5) (153) results in the
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formation of dimeric dimedone species 1a. The selenolate anion formed is readily oxidized
to the diselenide by dissolved O2 in the buffer. The generation of 1a would coincide with
the observation that new downfield alkyl resonances appeared during our 1H NMR time
course experiments.
In order to verify our hypothesis that 1a is a product of our proposed selenoPummerer reaction, we subjected an aliquot of the reaction between dimedone and
PhSeO2H for high performance liquid chromatography-mass spectrometry (LCMS)
analysis. Figure 29A displays the HPLC total total ion current (TIC) of the reaction
mixture, which shows the elution of two analytes with retention times of 18.3 min and 26.7
min, respectively. The resulting mass spectra obtained from the eluted analyte at t = 18.3
min is shown in Figure 29B. The spectrum shows a peak at m/z = 277.2, which was
identified as the [M+H]+ ion of 1a. In addition, the observation of a more intense peak at
m/z = 309.3, an increase of 32 Da, supports the existence of 1a as this mass corresponds to
the methanol adduct (1b). The alkene center of 1a is highly electrophilic and is unstable in
nucleophilic solvents. As a result, 1a could not be isolated through employment of standard
chromatographic conditions on SiO2, a result likely attributable to the highly electrophilic
character of this alkene. The mass spectrum obtained from the analyte observed at t = 26.7
min is shown in Figure 29C. It shows only one main ion at m/z = 303.4, which we attribute
to the [M+H]+ ion of the condensation product between two dimedone molecules and
acetone (2) (154). Acetone could be present due to either breakdown of dimedone during
the reaction or contamination of the reaction glassware. Purification of 2 on SiO2 yielded
1

H,

13

C{1H} and

13

C-DEPT135 NMR spectra, as well as elemental analysis data that
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matched the compound. One can envision a mechanism to produce 2 without direct redox
interaction with the selenium atom of a seleninic acid. As 2 is the minor product of the
reaction (see Figure 29A), it was of little significance to this study.
3.5. The presence of 1a as a chemical signature of seleninic acid in a model peptide
Recently a molecular probe was developed to detect protein Cys-sulfinic acids,
the sulfur-containing analog of Sec-seleninic acids (155). However, no similar chemical
probe is known to detect the presence of Sec-seleninic acid. Our findings detailed above
led us to pursue the use of 1a as a chemical footprint for the detection of Sec-seleninic
acid. We envisioned an assay in which a Sec-containing peptide or protein would be
exposed to H2O2 in the presence of dimedone. This could potentially generate a Secseleninic acid in situ that could react with dimedone to produce 1a, which could then be
detected by a LCMS experiment similar to the one presented in Figure 29.
To this end, we conducted an experiment where our model Sec-peptide, HPTVTGAUG-OH, was exposed to a 5 molar excess of H2O2 while incubated with a 2
molar excess of dimedone. The result from this experiment is shown in the top panel of
Figure 30. The extracted ion chromatogram shows that, under these conditions, 1a was
produced from dimedone’s reaction with the Sec-seleninic acid of peptide HPTVTGAUG-OH. Similar to in the case where methanol was the solvent, H2O adds to
the electrophilic alkene center of 1a to form adduct 1c when water is the solvent (see
Figure 30). In order to demonstrate that the presence of peptide H-PTVTGAUG-OH is
required for the generation of 1a, we conducted a control experiment where dimedone
was reacted with H2O2 alone. A small amount of 1a is present in this control experiment
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as shown in the bottom panel of Figure 30. However, during the course of this
experiment, an unknown, contaminating selenium-containing compound, eluted from the
column (identified by the characteristic isotope pattern of selenium). This contaminant is
most likely present from previous exposure of the LCMS system to selenopeptides. We
hypothesized that the excess H2O2 injected into the LCMS reacted with this seleniumcontaining compound to generate a seleninic acid in situ during separation on the LC
column, thereby generating 1a upon its reaction with dimedone. Further control
experiments using 1H NMR and direct-infusion ESI mass spectrometry provided
evidence for this claim as no reaction between dimedone and H2O2 was observed during
these experiments. Therefore, the selectivity of our proposed assay for seleninic acids is
confirmed in that the generation of 1a occurs in neither the presence of H2O2 nor sulfinic
acids.

DISCUSSION
As described in Figure 18, here we have revisited the quandary of why mTrxR
cannot be inhibited by dimedone, even though a Sec-selenenic acid, a strong electrophile,
must be formed upon reaction of the enzyme with H2O2 (84). Our curiosity led us to delve
into this problem based on two key observations that are described in the following two
sections.
4.1. Dimedone and Sec-selenenic acids
The first key observation came in the form of a literature search for the reported
pKa value of the β-hydrogens of dimedone, which we found to be ~5 (141). This low pKa
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renders dimedone a suitable leaving group in SN2-like reactions. Further motivation was
found in the form of multiple reports detailing the lability of both

-keto sulfides and

selenides towards thiols and selenols (156, 157, 158, 159, 160, 161, 162). The Secdimedone label comprises an α-diketo selenide, which we hypothesized would be even
more labile than the reported α-monoketo selenides. Coupled with the fact that C-Se
bonds are weaker than C-S bonds due to their lower-lying σ* orbital (163), we thought
that the Sec-dimedone bond might be labile to nucleophiles. This idea was supported by
our initial experiment where we showed that the wild type mTrxR-GCUG enzyme
retained full selenocystine reductase activity in the presence of H2O2 and dimedone,
whereas the mutant enzyme mTrxR-GGUG (no resolving Cys) only retained 74% of
selenocystine reductase activity under the same conditions. However, it was still unclear
whether the wild type enzyme was retaining activity due to the mechanism shown in
Figure 18A (resolution of Sec-selenenic acid by resolving Cys) or the mechanism in
Figure 18B (removal of dimedone label by resolving Cys).
To provide thorough evidence that the Sec-dimedone adduct is labile and that the
mechanism shown in Figure 18B is plausible, we turned to a peptide model to facilitate
our analysis. We explicitly chose to remove the resolving Cys residue from our model
wild type, peptide H-PTVTGCUG-OH. The reason behind this was to eliminate the
possibility of selenosulfide bond formation through the mechanism shown in Figure
18A. Reducing agents were added after the peptide was alkylated with dimedone to
mimic the resolving Cys in the enzyme and the results show that, indeed, the Secdimedone bond is labile.
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Possible mechanisms explaining the removal of the dimedone label on HPTVTGAUG-OH are shown in Figure 31. Whether βME (Figure 31A), TCEP (Figure
31B) or selenocystine/cystine (Figure 31C) are used as removal reagents, the selenium
atom of the Sec-dimedone adduct acts as the electrophile in mechanisms similar to the
one shown in Figure 17B, except here exogenous nucleophiles are used instead of the
resolving Cys residue of the peptide/enzyme. The 10-fold excess of βME and TCEP used
in this experiment is conservative when considering the theoretical effective molarity of
the adjacent, resolving Cys residue in the peptide/enzyme. The surprising result that
cystine (a disulfide compound) and selenocystine (a diselenide compound) were able to
partially remove the Sec-dimedone label (Figure 31C) demonstrates the lability of the
Sec-dimedone adduct.
An alternative mechanism to that shown in Figure 31C can also be envisioned in
which the selenide of the Sec-dimedone acs as nucleophile to attack an electrophilic
disulfide (cystine) or diselenide (selenocystine). The use of a selenide as a nucleophile is
not unprecedented (167). Indeed, it is this characteristic of selenides that led to the
development of a protecting group strategy that allows for the facile deprotection of Sec
residues protected with the p-methoxybenzyl group by our lab (147).
While our data provide evidence that the mechanism shown in Figure 17B may explain
why the wild type mTrxR-GCUG enzyme is not inhibited by dimedone in the presence of
H2O2, the data also demonstrate that dimedone may not be the most suitable molecular
probe to identify Sec-selenenic acids in proteins. In a previous report, K. S. Carroll et. al.
showed that the dimedone label of a Cys-containing dipeptide was stable over 12 h when
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exposed to reducing conditions of 10x DTT, TCEP, or GSH in potassium phosphate
buffer, pH 7.4 (151). In a subsequent report, the authors studied the stability of linear,
nucleophilic probes (designed to alkylate Cys-sulfenic acid) to similar reducing
conditions (155). Interestingly, they found that, for the most part, there was no direct
correlation between leaving group potential (pKa) and stability of the Cys-nucleophile
label. The weaker C–Se bond relative to the C–S bond most likely renders the Secdimedone adduct inherently labile when compared to the Cys-dimedone adduct. 4.2.
Dimedone and Sec-seleninic acids
Our second key observation, which led us to explore dimedone’s reactivity
towards seleninic acids, was the realization of the explicitly opposite nature of seleninic
acids when compared to sulfinic acids. Sulfinic acids are widely known as reducing
agents, whereas seleninic acids are considered weak oxidizing agents (50, 169, 170, 171).
The reducing (nucleophilic) property of sulfinic acids is exemplified when considering
the nature of the molecular probe that was recently developed for Cys-sulfinic acids (NOBio): the probe is electrophilic and is the recipient of electrons from a Cys-sulfinic acid
(155). On the other hand, the highly oxidative (electrophilic) nature of seleninic acids
allows them to be readily reduced by thiols and other, mild reducing agents such as
ascorbate (50, 172, 173, 174, 175).
Both PhSeO2H and MeSeO2H are inexpensive and commercially available and
served us well as model compounds to investigate dimedone’s reactivity towards
seleninic acids. The results from our 77Se NMR time course experiments and our LCMS
experiments using PhSeO2H and MeSeO2H showed that these seleninic acids were being
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reduced to the corresponding diselenide compounds and, as a result, were oxidizing
dimedone to the dimeric form 1a in the seleno-Pummerer reaction detailed in Figure 28.
We were initially disappointed that dimedone did not “tag” the model seleninic
acids, forming a stable adduct that could be detected and used to identify a protein Secseleninic acid. However, the formation of 1a led us to pursue the development of a
potential assay for Sec-seleninic acids. In the assay, 1a acts as a detectable chemical
footprint indicating that a transient Sec-seleninic acid had formed when Sec was oxidized
with H2O2. We had high confidence moving forward with the development with the
knowledge that both sulfinic acids and H2O2 itself are unreactive to dimedone, giving the
potential assay high selectivity for Sec-seleninic acid.
The validity of the assay was confirmed during our experiments with model
peptide H-PTVTGAUG-OH. In this case, the Sec-seleninic acids were generated in situ
to mimic conditions that would occur in both in vitro and in vivo assays. We were able to
detect the formation of 1a via LCMS after exposing the peptide H-PTVTGAUG-OH to a
5-molar excess of H2O2 and a 2-molar excess of dimedone. A large excess of dimedone
relative to peptide is not required for the formation of 1a, indicating reasonably fast
reaction kinetics for assay viability. This report marks the first time a molecular probe
has been used to identify the presence of a Sec-seleninic acid.
To date, the transient seleninic acid species has been detected only by 77Se NMR
(175, 176, 177, 178, 179, 180, 181), X-ray crystallography (180, 182), and mass
spectrometry (185,186). However, these methods of detection are not ideal. For instance,
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Se NMR is a very insensitive technique with sensitivity similar to 13C{1H} NMR,
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owing to its slightly higher natural abundance but lower gyromagnetic ratio relative to
13

C (187). Therefore, detection of protein Sec-seleninic acids via this method is difficult.

Moreover, X-ray crystallography is only amenable to those Sec-seleninic acids that are
stabilized by the protein microenvironment, as in the case with selenosubtilisin and
glutathione peroxidase (183, 184). Finally, detection of protein Sec-seleninic acids by
mass spectrometry is unreliable due to their high reactivity. The shortcomings of these
methods to detect Sec-seleninic acids render the potential assay we have developed, using
1a as a detectable chemical footprint, advantageous for Sec-seleninic acid detection.
Further development is currently underway in our lab to refine this assay to make it
viable for in vivo detection of Sec-seleninic acids.
5. CONCLUSIONS
This report has clearly demonstrated the differences in the chemical properties of
Cys-sulfenic acid and Sec-selenenic acid towards alkylation by dimedone. A Cysdimedone adduct is much more stable towards nucleophiles compared to a Sec-dimedone
adduct, which is labile towards nucleophiles. The lability of the Sec-dimedone adduct is
problematic for the detection of Sec-selenenic acids under in vivo conditions due to the
presence of glutathione. Further differences between S-oxides and Se-oxides is
demonstrated by the finding that Cys-sulfinic acid is unreactive towards dimedone, while
Sec-seleninic acid reacts with dimedone to yield and a diselenide and a dimedone dimer,
the latter forms as a result of the seleno-Pummerer reaction. The presence of the
dimedone dimer may possibly be used in the future for the detection of transient Secseleninic acids in enzymes/proteins.
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Figure 16.

Figure 16. Possible fates of Sec-selenenic acid in mTrxR. (A) Oxidation of Sec in mTrxR
by H2O2 to form Sec-selenenic acid, followed by resolution by the adjacent Cys residue
resulting in the formation of a selenosulfide bond and concomitant enzyme recovery from
oxidation. (B) Theoretical inhibition of mTrxR by dimedone via alkylation of Secselenenic acid.
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Figure 17.

Figure 17. Possible reasons for the absence of inhibition of thioredoxin reductase by
dimedone in the presence of H2O2. (A) Rapid resolution of Sec-selenenic acid by the
adjacent Cys residue prevents alkylation. (B) Alkylation of Sec-selenenic acid by
dimedone, followed by removal of the dimedone label (pKa ~ 5)9 by attack of the adjacent
Cys residue. (C) Over oxidation of Sec to Sec-seleninic acid, whose reactivity towards
dimedone is heretofore unknown.
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Table 2.

Enzyme

% Selenocystine
Reductase Activity
Remaining

mTrxR-GGUG

74 ± 1

mTrxR-GCUG

101 ± 3

Table 2. Inhibition of wild type mammalian
thioredoxin reductase (mTrxR-GCUG) or
mutant thioredoxin reductase (mTrxR-GGUG)
by dimedone treatment in presence of H2O2.
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Figure 18.

Figure 18. (A) Extracted ion chromatogram monitoring the elution of the reaction of the
oxidized, wild type peptide H-PTVTGCUG-OH (5 μM) after reduction with TCEP (50
μM) in 100 mM potassium phosphate buffer, pH 7.0 for 15 min and reaction with 10 mM
iodoacetic acid in the dark with shaking at room temperature for 25 min. (B) Mass
spectrogram of the eluted peak 27.05 min shown in (A). The m/z at 901.6 in the mass
spectrogram corresponds to the dicarboxymethylated peptide.
89

Figure 19.

Figure 19. (A) Extracted ion chromatogram monitoring the elution of the reaction of the
oxidized, wild type peptide H-PTVTGCUG-OH (5 μM) after reduction with TCEP (50
μM) in 100 mM potassium phosphate buffer, pH 7.0 for 15 min, followed by reaction with
50 mM dimedone and 5 mM H2O2 with shaking at room temperature for 25 min. (B) Mass
spectrogram of the eluted peak 27.69 min shown in (A). The m/z at 783.4 in the mass
spectrogram corresponds to the oxidized, wild type peptide with no alkylation by dimedone.
The m/z at 141.0 corresponds to the mass of dimedone.
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Figure 20.

Figure 20. (A) Extracted ion chromatogram monitoring the elution of the reaction of the
oxidized, wild type peptide H-PTVTGCUG-OH (5 μM) after reduction with TCEP (50
μM) in 100 mM potassium phosphate buffer, pH 7.0 for 15 min, followed by reaction
with 500 mM dimedone and 5 mM H2O2 with shaking at room temperature for 25 min.
(B) Mass spectrogram of the eluted peak 28.09 min shown in (A). The m/z at 783.4 in the
mass spectrogram corresponds to the oxidized, wild type peptide with no alkylation by
dimedone. The m/z at 141.0 corresponds to the mass of dimedone.
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Figure 21.

Figure 21. Alkylation of model Sec-containing peptide with dimedone. Sec was initially
protected as Sec(5-Npys) to prevent oxidation of the selenium atom. Ascorbate selectively
removes 5-Npys protecting group from Sec, generating a free Sec-selenol, which was then
oxidized by H2O2 in the presence of dimedone to alkylate the Sec-selenenic acid.
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Figure 22.

Figure 22. (A) Extracted ion chromatogram monitoring the elution of species with m/z
values of 751.8 (blue) or 891.3 (red) after exposing peptide PTVTGAUG to alkylation
conditions of 5 μM PTVTGAUG, 5 μM H2O2, and 50 μM dimedone for 25 min in 100 mM
potassium phosphate buffer, pH 7.0. These m/z values correspond to the PTVTGAUG
peptide as the diselenide and dimedone-labeled PTVTGAUG peptide, respectively. It is
clear that, under these alkylation conditions, the Sec-containing peptide PTVTGAUG is
oxidized to the selenenic acid and subsequently alkylated with dimedone. (B) Mass
spectrum of the analyte at rt = 17.65 min. In the mass spectrum, the most intense ion is the
PTVTGAUG diselenide peptide at m/z = 751.8. (C) Mass spectrum of the analyte at rt =
18.00 min. In the mass spectrum, the most intense ion is the dimedone-labeled
PTVTGAUG peptide at m/z = 891.3.
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Figure 23.

Figure 23. Extracted ion chromatograms monitoring the elution of species with m/z values
of 751.8 and 752.8 (blue), 891.3 (red), 829.3 (green), 871.3 (magenta), and 920.2
(tangerine) after exposing dimedone-labeled peptide PTVTGAUG to conditions of (top to
bottom): no reducing agent, 10x βME, 10x TCEP, 1000x cystine, or 1000x selenocystine
for 15 min in 100 mM potassium phosphate buffer, pH 7.0. These m/z values correspond
to peptide PTVTGAUG as the selenol (m/z 752.8), peptide PTVTGAUG as the diselenide
(m/z 751.8), dimedone-labeled peptide PTVTGAUG (m/z 891.3), the βME adduct of
peptide PTVTGAUG (m/z 829.3), the cysteine adduct of peptide PTVTGAUG (m/z 871.3),
and the selenocysteine adduct of peptide PTVTGAUG (m/z 920.2), respectively. The
lability of the Sec-dimedone label is demonstrated by the cases where reducing agent was
added (βME and TCEP), which resulted in the amount of dimedone-labeled PTVTGAUG
decreasing substantially with a corresponding increase in the amount of peptide-βME
adduct and/or peptide in the reduced, selenol form. The lability of the Sec-dimedone label
is further demonstrated by the removal of the dimedone label upon exposure to disulfide
(cystine) or diselenide (selenocystine) compounds, both of which are expected to be
chemically inert to alkyl selenides. Addition of cystine results in the formation of a
cysteinyl-peptide adduct, while addition of selenocystine results in the formation of a
selenocysteinyl-peptide adduct.
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Figure 24.

Figure 24. 77Se NMR time course of the reaction between 100 mM PhSeO2H and 200 mM
dimedone in CD3OD. After 6 h of reaction time, the only observable resonance in the 77Se
NMR spectrum was diphenyl diselenide.
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Figure 25.

Figure 25. 77Se NMR time course of the reaction between 100 mM MeSeO2H and 200
mM dimedone in CD3OD. After 30 min of reaction time, the only observable resonance
in the 77Se NMR spectrum was dimethyl diselenide.
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Figure 26.

Figure 26. 1H NMR time course of the reaction between 100 mM PhSO2H with 200 mM
dimedone in CD3OD. No reaction observed.
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Figure 27.

Figure 27. (bottom) 1H NMR spectrum of 100 mM p-TsOH in CD3OD. (middle) 1H NMR
spectrum of 200 mM dimedone in CD3OD. (top) 1H NMR spectrum of 100 mM p-TsOH
and 200 mM dimedone in CD3OD after 24 h.
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Figure 28.

Figure 28. Proposed mechanism of the reaction of dimedone with seleninic acids. The
elimination of a selenolate anion in the second-to-last step of the mechanism produces the
dimeric dimedone species 1a. The selenolate anion is then immediately oxidized to the
diselenide by dissolved O2 to the more stable diselenide species.
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Figure 29.

Figure 29. (A) HPLC total ion current (TIC) of the reaction between 200 mM dimedone
and 100 mM PhSeO2H in MeOH after 48 h of reaction time (red). The water blank is
shown in blue. Two major analyte elution profiles were observed with retention times of
18.1 min and 26.5 min, respectively. (B) Mass spectrum of the analyte at t = 18.1 min in
the TIC. This analyte was attributed to the dimeric dimedone species produced by the
seleno-Pummerer reaction (1a; m/z = 277.2), which exists in equilibrium with its
methanol adduct (1b; m/z = 309.3) (C) Mass spectrum of the analyte at t = 26.5 min in
the TIC. This analyte was attributed to the condensation product between two dimedone
molecules and acetone (2; m/z = 303.4
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Figure 30.

Figure 30. Extracted ion chromatograms monitoring the elution of species with m/z
values of 751.8 and 752.8 (blue), 277.2 (red, solid), 295.0 (red, dashed), and 141.0
(green) after (top) the reaction of 1 mM peptide PTVTGAUG, 5 mM H2O2, and 2 mM
dimedone in 100 mM potassium phosphate buffer, pH 7.4 for 25 min, or (bottom) the
reaction of 5 mM H2O2 and 2 mM dimedone in 100 mM potassium phosphate buffer, pH
7.4 for 25 min. These m/z values correspond to peptide PTVTGAUG as the selenol (m/z
752.8), peptide PTVTGAUG as the diselenide (m/z 751.8), dimeric dimedone species 1a
(m/z 277.2), the water adduct of 1 (1c; m/z 295.0), and dimedone (m/z = 141.0),
respectively. The top panel demonstrates that 1a can be used as a chemical footprint for
the detection of Sec-seleninic acid under conditions of oxidative stress (5x molar excess
of H2O2 in this case). The bottom panel shows a control experiment in which the Seccontaining peptide PTVTGAUG is absent, but dimedone (2 mM) and H2O2 (5 mM) are
present.
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Figure 31.

Figure 31. Mechanistic explanation for the lability of the Sec-dimedone label. (A) The
thiol moiety of βME attacks the electrophilic Se atom of Sec and dimedone acts as the
leaving group. (B) TCEP acts as the nucleophile and attacks the electrophilic Se atom of
Sec and dimedone acts as the leaving group. The nascent phosphonium ion is then rapidly
hydrolyzed to yield a phosphine oxide and free Sec-selenol residue. (C) The selenium atom
of Sec acts as the nucleophile and attacks the disulfide/diselenide moiety of either cystine
or selenocystine to form a decavalent Se species. The thiolate/selenolate anion formed
during the exchange reaction then attacks the electrophilic carbon of the dimedone moiety,
returning electrons to Se and removing the label.
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Chapter 4:
Sec and Thioredoxin Reductase
One Electron Reductions

Figure 32. Single electron reduction by Sec. Sec is capable of forming a stable radical.
We hypothesis that this allows it to catalyze single electron reductions. In this example
Sec is reduce the ascorbyl radical, which is a one electron substrate.
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Here we investigate one gain of function Sec may impart to an enzyme, the
enhancement of one-electron transfer catalysis. We compared the ability of Seccontaining mTrxR2 to catalyze the reduction of bovine cytochrome c, ascorbyl radical,
and dehydroascorbate in comparison to Cys-containing thioredoxin reductases from
DmTrxR and PfTrxR. The Sec-containing mTrxR2 was able to reduce all three
substrates, while the Cys-containing enzymes had little or no activity. In addition, we
constructed Cys→Sec mutants of DmTrxR and PfTrxR and found that this substitution
resulted in a gain of function, as these mutant enzymes were now able to catalyze the
reduction of these substrates. We also found that in the case of PfTrxR, reduction of
cytochrome c was enhanced 5-fold in a truncated PfTrxR in which the C-terminal redox
center was removed. This shows that some of the ability of thioredoxin reductase to
reduce this substrate comes from the flavin coenzyme. We also discuss a possible
mechanism by which Sec-containing thioredoxin reductase reduces dehydroascorbate to
ascorbate by two, sequential one-electron reductions, in part catalyzed by Sec.
Sec: A Gain of Function
The catalytic role that Sec plays in the reduction of Trx by TrxR has been
established; Sec accelerates the rate of thiol/disulfide exchange reactions by being both a
good electrophile and nucleophile (52, 63, 66, 68). While mutation of Sec to Cys results
in a large loss in catalytic activity in the mammalian enzyme, Sec is not chemically
necessary for the reduction of Trx because orthologous TrxRs from other species catalyze
the same reaction but use Cys instead of Sec (115). As this is the case, then why has the
mammalian form of the enzyme evolved to use Sec?
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One answer is that the use of Sec in the enzyme imparts some gain of function
that Cys cannot catalyze. One such gain of function is the ability to resist oxidative
inactivation by two-electron oxidations, as has been experimentally found for TrxR,
[NiFeSe]-hydrogenases, and selenosubtilisin (77, 82, 195).
Koppenol and coworkers have provided a thermodynamic rationale for the use of
Sec in enzymes; the selanyl radical is more stable than a thiyl radical by ~47 kJ/mol (18).
This analysis is based on the redox potential of the RS•/RSH pair (Eº = 0.92 V)
compared to the RSe•/RSeH pair (Eº = 0.43 V) (69, 70). Their analysis showed that the
instability of the thiyl radical could lead to C-H abstraction leading to destruction of the
protein/enzyme (70). In contrast, they posited that the higher stability of the selanyl
radical could lead to its repair by ascorbate with a rate constant of 8 x 107 M-1 s-1 (69, 70).
Alternatively, the selanyl radical could react with molecular oxygen to form a
selanylperoxyl radical (Sec-SeOO•), which could be reduced by a thiol to form a
selenosulfide, O2•–, and H+ (70). Overall, this analysis shows that Sec also imparts the
ability to resist one-electron oxidations.
The ability to resist one-electron oxidations might be especially important in
mTrxR because it is a flavoenzyme, and flavoenzymes inherently react with molecular
oxygen to produce superoxide (196, 197). Thus the use of Sec in mTrxR would be
advantageous since adventitious transfer of electrons from the reduced flavin to the Cterminal selenosulfide would result in a selanyl radical that would not inactivate the
enzyme, unlike the situation in Cys-ortholog TrxRs.
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The results of Koppenol and coworkers led us to hypothesize that the use of Sec
might impart an additional gain of function not yet realized. mTrxR has been shown to
reduce both the ascorbyl radical and cytochrome c (71, 72). Both of these reactions
require one electron transfers, with the ascorbyl radical being reduced to ascorbate (Asc)
and the ferric iron of oxidized cytochrome c being reduced to ferrous iron. Is this
expanded substrate specificity due to the presence of Sec? Here we test this possibility by
testing the ability of Sec-containing TrxRs to catalyze the reduction of cytochrome c, the
ascorbyl radical and DHAA in comparison to Cys-containing orthologs.
For these experiments we used Sec-containing mTrxR2, Cys-containing
thioredoxin reductase from DmTrxR, and Cys-containing thioredoxin reductase from
PfTrxR. For the Cys-containing ortholog enzymes, we also constructed mutants in which
we performed a Cys→Sec replacement using protein semisynthesis (129). The results
show that the Sec-containing enzymes are capable of catalyzing one-electron transfer
reactions, but the Cys-containing enzymes are not.

METHODS
Enzyme Production. The enzymes used in this study are listed in Table 3. The
production and purification of these enzymes has been reported previously (77, 129,
124). Enzymes 2, 3, 5, 6, 8, 10, and 11 were produced as recombinant proteins as an
intein-fusion protein as previously described (77, 129, 124). Sec-containing enzymes 1, 4,
7, and 9 were produced using intein-mediated peptide ligation using a procedure
described below (77, 129, 124).
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E. coli cells containing the plasmid for a truncated TrxR-intein-CBD were grown in
either TB or LB medium. The cell culture, containing 0.2 µg/mL ampicillin, was grown
at 37 °C until the OD600 reached ~0.6. The cells were then cooled to 20 °C, and IPTG
was added to induce expression to a final concentration of 0.5 mM, followed by
incubation at 20 °C overnight on a rotary shaker (200 rpm). The cells were harvested by
centrifugation. The harvested bacterial cell pellet was equilibrated in chitin buffer A [50
mM MOPS and 150 mM NaCl (pH 7.0)] followed by cell lysis with pulse sonication. The
lysed slurry was then pelleted via centrifugation and the cleared lysate was loaded onto a
chitin-agarose column pre-equilibrated with chitin buffer A. The intein-CBD fused to a
truncated TrxR (mTrxR3, DmTrxR3, PfTrxR3, or PfTrxR7) allowed it to bind to
the resin with high specificity. Note that the designation “” followed by a number
denotes a truncated enzyme of x amino acids missing from the C-terminus. The loaded
truncated TrxR protein was with chitin buffer A until the absorbance of the effluent was
the same as the buffer wash. This was followed by additional washing with 0.5 L of highsalt chitin buffer B [50 mM MOPS and 500 mM NaCl (pH 7.0)]. The resin was then
removed from the column and enough chitin buffer B was added to make a compact
buffer-resin slurry.
The semisynthetic Sec-containing TrxR enzymes were produced via ligation of
the desired synthetic peptides to the truncated TrxR containing a C-terminal thioester
reactive group. Simultaneous cleavage of the fusion protein from the intein and ligation
with synthetic peptide were achieved by addition of a cleavage cocktail consisting of 120
mM NMA and the desired synthetic peptide in chitin buffer B (pH 8.0−8.5). The
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cleavage and ligation reaction was done at room temperature overnight with constant
shaking. Following overnight incubation in a conical tube, the resin/chitin slurry was
poured back onto the column and the excess buffer was drained from the column. Next,
the column was washed with three column volumes of chitin buffer B. The semisynthetic
enzyme was concentrated and buffer exchanged with buffer C [1 M NH4SO3, 50 mM Tris
pH 7.5] via ultrafiltration (Amicon Ultracel 30 kDa cut off filters). It was then loaded by
gravity onto a pre-equilibrated phenyl sepharose column (20 mL). After the sample was
washed with buffer C, the semisynthetic TrxR enzyme was eluted from the phenyl
sepharose column with buffer lacking NH4SO3 [50 mM Tris pH 7.5], to disrupt binding
to the column. The fractions containing semisynthetic TrxR were confirmed by
spectrophotometry and SDS-PAGE, pooled, and then buffer exchanged through
ultrafiltration with storage buffer [50 mM potassium phosphate, 500 mM NaCl, and 1
mM EDTA (pH 8.0)]. The concentration of each semisynthetic TrxR enzyme was
determined through spectral analysis via the absorbance maximum of the flavin at 460
nm ( = 22.6 mM-1cm-1, representing the dimer).
Reduction of cytochrome c by TrxR.
Reactions to determine the ability of TrxR to reduce cytochrome c were
conducted in 100 mM potassium phosphate pH 7.0, 200 mM NADPH, 1 mM EDTA,
varying amounts of superoxide dismutase (SOD), and 100 mM cytochrome c in a final
reaction volume of 500 mL. SOD was used to quench superoxide produced as a result of
the NADPH oxidase activity of TrxR. Superoxide can readily reduce cytochrome c (72).
Reactions were allowed to incubate at room temperature for one min after which 100 nM
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TrxR was added to initiate the reaction. Reduction of cytochrome c was determined by
measuring the change in absorbance at 550 nm using the extinction coefficient of 28.0
mM-1. Controls were done in the same manner however no TrxR was added.
Reduction of the ascorbyl radical by TrxR.
Ascorbyl radical was produced as described previously by May (71). Briefly, the
radical was produced by mixing 1 mM L-ascorbic acid sodium salt with varying amounts
of ascorbate oxidase (AO) in 50 mM Tris buffer, pH 7, 1 mM EDTA, and 200 µM
NADPH. The final reaction volumes were 500 mL. Assays were conducted by allowing
ascorbate oxidase and 100 nM TrxR to incubate together for 2 min at room temperature,
after which 1 mM ascorbate was added. Activity was determined by measuring NAPDH
consumption spectrophotometrically at 340 nm using an extinction coefficient of 6220 M1

cm-1 (199). The activity was calculated using a stoichiometric ratio of one mole of

NADPH to two moles of ascorbyl radical (4). Background NADPH consumption was
corrected for by subtracting control experiment activities in which no ascorbate was
present as well as an additional control in which no TrxR was present.
Reduction of DHAA by TrxR.
Reactions monitoring the reduction of DHAA were carried out in 100 mM
potassium phosphate pH 7.0, 1 mM EDTA, 200 mM NADPH, and 500 mM DHAA.
Following a 1 min incubation of buffer and substrate, 250 nM TrxR was added to initiate
the reaction in a final assay volume of 500 mL. Activity was determined by measuring
NAPDH consumption spectrophotometrically at 340 nm using an extinction coefficient
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of 6220 M-1 cm-1. Background NADPH consumption was corrected for by subtracting
control experiment activities in which no DHAA was present as well as an additional
control in which no TrxR was present.
RESULTS
Reduction of cytochrome c by thioredoxin reductase.
Human mitochondrial and cytosolic TrxR have been shown to reduce cytochrome
c (72). The heme group of cytochrome c is capable of accepting a single electron as the
oxidized form contains Fe3+, which is reduced to Fe2+ upon reduction by one electron. As
with all of our enzyme assays, we compared the ability of Sec-containing TrxRs to Cyscontaining orthologs to reduce cytochrome c in order to determine the role of Sec in
accelerating catalysis of the one-electron transfer reaction. All enzymes utilized in our
experiments are listed in Table 3 and are grouped into different categories. Group 1
(enzymes 1-3) are variants of mTrxR2; enzyme 1 is the wild type (WT) enzyme, enzyme
2 is the Cys-mutant, and enzyme 3 is the truncated enzyme. Group 2 (enzymes 4-6) are
variants of DmTrxR; enzyme 5 is the WT enzyme (contains Cys), enzyme 4 is the
Cys→Sec mutant, and enzyme 6 is the truncated enzyme. Group 3 are variants of
PfTrxR; enzyme 8 is the WT enzyme (contains Cys), enzyme 7 is the Cys→Sec mutant,
and enzyme 11 is the truncated enzyme. PfTrxR is a different type of Cys-TrxR
compared to DmTrxR. The C-terminal tail of PfTrxR is longer and has four residues in
between the two redox active Cys residues, whereas the redox active Cys residues in
DmTrxR are adjacent. The enzymes of group 4 are “hybrid” enzymes in which we
grafted on the “tail” of the mammalian enzyme (GCUG or GCCG) onto the “body” of the
111

PfTrxR enzyme. Enzyme 9 is the Sec-containing PfTrxR hybrid, while enzyme 10 is the
Cys-containing TrxR hybrid.
Our results indicate that the Sec containing enzymes (1, 4, 7, and 9) are capable of
reducing cytochrome c to a much greater extent compared to their Cys-containing
orthologs as indicated by the increase in absorbance at 550 nm (Figure 33). All of the
Cys-containing enzymes, mTrxR2-GCCG (2), DmTrxR-SCCS (5), PfTrxRGCGGGKCG (8), and hybrid PfTrxR-GCCG (10) had comparatively low cytochrome c
reductase activity. However, enzymes DmTrxR-SCCS (5) and PfTrxR-GCGGGKCG (8)
had activities that were above background levels. All of the truncated enzymes (3, 6, and
11) also had activities that were above background. Of special note is the truncated
PfTrxR (11), which had the highest activity of all of the enzymes assayed in this study
(Table 4).
Reduction of the ascorbyl radical by thioredoxin reductase.
It has been shown that Sec-containing TrxR1 is capable of reducing the ascorbyl
radical (71). Here we show that the one-electron reduction of the ascorbyl radical to
ascorbate is highly dependent upon Sec in all of the TrxR variants examined in this study.
We determined this by generating the ascorbyl radical in situ with AO and then
measuring the consumption of NADPH as indicated by the decrease in absorbance at 340
nm (Figure 34). As is clearly shown in Figure 34 and the calculated activities in Table
5, all of the Sec-containing enzymes were capable of reducing the ascorbyl radical, but
none of the Cys-containing enzymes were able to do so, nor were the truncated enzymes.
The truncated PfTrxR (11) could not reduce the ascorbyl radical, unlike the case in which
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the truncated PfTrxR had very high cytochrome c-reductase activity. This data clearly
indicates that this one-electron transfer reaction is dependent upon Sec. Of very special
note, we found that the “hybrid” Sec-containing enzyme, PfTrxR-GCUG (9) was the
most active enzyme in our assay (Table 5).
Reduction of DHAA by TrxR.
A previous study showed that DHAA can be reduced by Sec-containing TrxR-1
(190). Identical to the studies above, here we demonstrate that the ability of TrxR to
reduce DHAA is dependent upon the presence of Sec as can be seen by the results of our
DHAA-reductase assay in Figure 35. Both DmTrxR and PfTrxR are naturally occurring
Cys-containing enzymes and these enzymes do not have any DHAA-reductase activity.
However, when the active site Cys residue is changed to Sec, as is the case for enzymes 4
and 7, the DHAA-reductase activity is dramatically increased. Conversely, when the Sec
residue of enzyme 1 is mutated to Cys, as is the case for enzyme 2, loss of activity
results. Just as we observed in our ascorbyl radical reductase assay, the hybrid Seccontaining PfTrxR had very high DHAA-reductase activity in comparison to the other
Sec-containing TrxRs (Table 6).
DISCUSSION
Reduction of cytochrome c by thioredoxin reductase.
All of the TrxRs in this study are high molecular weight enzymes that function as
head-to-tail dimers. NADPH binds near the tightly bound FAD coenzyme and reduces it
to FADH2. FADH2 then reduces a N-terminal disulfide redox center, usually of sequence
CVNVGC. The reduced N-terminal redox center then transfers two electrons to a C113

terminal redox center on the opposite subunit. The C-terminal redox centers of mTrxR2
and DmTrxR are similar in that they contain either a vicinal Cys-Sec motif, or vicinal
Cys-Cys motif. DmTrxR is structurally similar to mTrxR2 and we have used it for direct
mechanistic comparisons since it catalyzes the reduction of Trx with Cys instead of Sec
(122). The PfTrxR enzyme is different in comparison to these two enzymes because the
C-terminal redox center has the sequence Gly-Cys-Gly-Gly-Gly-Lys-Cys-Gly, but the
flow of electrons from NADPH to the C-terminal redox center is the same in all three
enzymes.
It is clear from the data in Figure 33 and Table 4 that the presence of Sec greatly
enhances the catalytic reduction of Fe3+ to Fe2+ in cytochrome c. This determination is
made by directly comparing the Sec-containing enzyme to its Cys-ortholog (compare
enzymes 1 and 2, 4 and 5, 7 and 8, and 9 and 10). This enhancement ranges from 2.2-fold
(enzymes 7 and 8) to 9-fold (enzymes 9 and 10). This enhancement is probably an
underestimate because these numbers are based upon the very low activity of the Cyscontaining enzymes, which have activities that are just above the detectable limit.
However, it is also clear that the FAD coenzyme is responsible for most of the
cytochrome c-reductase activity in the case of the Cys-containing TrxRs as evidenced by
the fact that the truncated mTrxR2 (enzyme 3) and the truncated DmTrxR (enzyme 6)
have similar activities (Table 4). This point is made dramatically clear by the very high
cytochrome c-reductase activity of the truncated PfTrxR (enzyme 11). In this case,
removal of the C-terminal tail of PfTrxR must enable access of cytochrome c to the Nterminal redox center and the FAD coenzyme. The high activity of the truncated PfTrxR
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should be unsurprising since it has been previously established that flavins can directly
reduce cytochrome c in solution (200). We present a model for the reduction of
cytochrome c by Sec-containing TrxR and truncated TrxR in Figure 36.
Reduction of the ascorbyl radical and DHA by thioredoxin reductase.
As the data clearly shows in Figures 31 and 32, and summarized in Tables 5 and 6, Sec
is chemically necessary for the reduction of both the ascorbyl radical and DHAA. None
of the Cys-containing TrxRs or the truncated TrxRs were capable of reducing these
substrates. While the ascorbyl radical must be reduced to ascorbate through a oneelectron reduction mechanism, DHAA could be reduced to ascorbate by either a oneelectron or two-electron mechanism as shown in Figure 37. It is known that DHAA is
reduced to ascorbate by glutaredoxin (thioltransferase) and protein disulfide isomerase
(PDI), both Cys-containing enzymes, by a two-electron mechanism (201, 202). These
enzymes form a covalent intermediate with DHAA, making the assignment of a twoelectron reaction mechanism unambiguous (202). This suggests that in principle, the Cyscontaining TrxRs studied here are capable of reducing DHAA as well. The fact that they
cannot do so, suggests that the reason the Sec-containing TrxRs can reduce DHAA is due
to the ability of Sec to efficiently catalyze one-electron transfer reactions as shown by the
lower pathway in Figure 37. This hypothesis is supported by the fact that the ascorbyl
radical can only be reduced to ascorbate through a one-electron mechanism and only the
Sec-containing TrxRs are capable of catalyzing this reaction.
The presence of Sec and the amino acid sequence of the C-terminal tail has a dramatic
effect on the activity of PfTrxR.
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As discussed earlier, PfTrxR has a very different C-terminal tail in comparison to
other high molecular weight TrxRs. A very interesting result of our study is that the Seccontaining PfTrxR enzymes (7 and 9) that we constructed have a dramatic gain of
function. In the case of enzyme 7, this gain of function is solely due to the replacement of
Cys with Sec. This can be visually seen by comparing the red and blue traces of Figure
34C and Figure 35C. In the case of enzyme 9, the gain of function is also due to the
replacement of Cys with Sec as is seen upon comparing the red and blue trace of Figure
34D and Figure 35D. However, there is also an additional gain of function when the
amino acid composition of the C-terminal redox center is changed from GCGGGKUG
(enzyme 7) to GCUG (enzyme 9). Both enzyme 7 and enzyme 9 contain Sec, but the
change in amino acid sequence results in a significant increase in ascorbyl radicalreductase activity as can be seen by comparing the red trace of Figure 34D with the red
trade of Figure 35C. A similar gain of function (5.5-fold) due to change in amino acid
composition of the C-terminal redox center is seen in the increased DHAA-reductase
activity as is seen upon comparing the red trace of Figure 35D with the red trace of
Figure 35C.
We offer two explanations for the large gain of function discussed above. First,
the increased ability of Sec to catalyze one-electron transfer reactions greatly accelerates
the rate of reaction in comparison to the Cys-containing enzyme with the same amino
acid sequence of the C-terminal redox center. Second, the transfer of electrons from the
N-terminal redox center to the C-terminal redox center is accelerated when size of the
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selenosulfide ring is changed from 20 atoms, as occurs in the sequence GCGGGKUG, to
8 atoms, as occurs in the sequence GCUG.
As catalysis of the ascorbyl radical and DHAA is greatly increased by change of
the amino sequence from GCGGGKCG in the native enzyme to GCUG, it is interesting
to speculate why nature did not evolve PfTrR in this way. P. falciparum has the
necessary genes to encode selenoproteins (203), but PfTrxR contains Cys not Sec. While
the reason for the absence of Sec in the enzyme is not known at the moment, we can
speculate that the additional gain of function that we observed here may be somehow
deleterious to the redox biology of P. falciparum.

CONCLUSION
Our results clearly demonstrate that TrxR requires Sec to catalyze one-electron
reductions of the ascorbyl radical and cytochrome c. Both of these molecules were
previously shown to be substrates for mammalian TrxR, but here we have provided
definitive evidence that reduction of these substrates are dependent upon Sec as shown by
comparison with Cys-ortholog enzymes. The reduction of DHAA to ascorbate is also
dependent upon Sec and this may be due to the ability of Sec to catalyze a series of oneelectron transfer reactions, though we did not provide definitive evidence for this
hypothesis here. The biological importance of Sec is a widely debated topic (50,204,120).
We had previously shown that Sec imparts resistance to oxidative inactivation, (77) while
our current work establishes that Sec can impart enzymes with the ability to catalyze
single electron transfers. This suggests that Sec may impart more than one gain of
function.
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Table 3.
Enzyme
Group
Group 1

Group 2

Group 3

Group 4
Group
3/4

Enzyme
abbreviation
mTrxR2-GCUGa
mTrxR2-GCCG
mTrxR2Δ8

Enzyme
number
1
2
3

Contain
Sec?
yes
no
no

DmTrxR-SCUG
DmTrxR-SCCSa
DmTrxRΔ8

4
5
6

yes
no
no

PfTrxRGCGGGKUG
PfTrxRGCGGGKCGa
PfTrxR-GCUGb
PfTrxR-GCCGb
PfTrxRΔ7

7

yes

Sequence of Cterminal redox site
GCUG
GCCG
C-terminal deletion of 8
residues
SCUG
SCCS
C-terminal deletion of 8
residues
GCGGGKUG

8

no

GCGGGKCG

9
10
11

yes
no
no

GCUG
GCCG
C-terminal deletion of 7
residues

Table 3. Enzyme constructs used in this study.
a

Indicates the wild type enzyme
b
Indicates a hybrid PfTrxR enzyme.
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Figure 33.
A

B

C

D

Figure 33. Plots of A550 vs. time for cytochrome c-reductase activity assays of the
thioredoxin reductase enzymes in this study. For each plot, the red trace is the Seccontaining enzyme, the blue trace is the Cys-containing enzyme, the green trace is the
truncated enzyme, and the black trace is the control. Each trace is the average trace of
three experiments. (A) Plot of the mTrxR2 constructs (enzymes 1-3). (B) Plot of the
DmTrxR constructs (enzymes 4-6). (C) Plot of the PfTrxR constructs (enzymes 7, 8, 11).
(D) Plots of the PfTrxR hybrid constructs (enzymes 9-11).
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Table 4.
Enzyme
abbreviation

mTrxR2-GCUG
mTrxR2-GCCG
mTrxR2Δ8
DmTrxR-SCUG
DmTrxR-SCCS
DmTrxRΔ8
PfTrxRGCGGGKUG
PfTrxRGCGGGKCG
PfTrxR-GCUG
PfTrxR-GCCG
PfTrxRΔ7

Enzyme
number

cytochrome c (mmol
cyt c/min/mol
enzyme)b

1
2
3
4
5
6
7

cytochrome c reductase
activity
(pmoles cytochrome
c/min)a
151 ± 10
23 ± 10
34 ± 12
182 ± 14
51 ± 8
76 ± 10
112 ± 21

8

50 ± 7

1000 ± 144

9
10
11

133 ± 20
15 ± 12
240 ± 22

2667 ± 394

3012 ± 199
452 ± 197
679 ± 233
3642 ± 286
1012 ±161
1512 ± 21
2238 ± 426

297 ± 248
4726 ± 439

Table 4. Calculated cytochrome c reductase activities of the thioredoxin reductases in
this study. aActivity is recorded as pmoles of cytochrome c reduced per min.
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Figure 34.
A

B

C

D

Figure 34. Plots of A340 vs. time for asorbyl radical-reductase-activity assays for the
thioredoxin reductases in this study. For each plot, the red trace is the Sec-containing
enzyme, the blue trace is the Cys-containing enzyme, the green trace is the truncated
enzyme, and the black trace is the control. Each trace is the average trace of three
experiments. (A) Plot of the mTrxR2 constructs (enzymes 1-3). (B) Plot of the DmTrxR
constructs (enzymes 4-6). (C) Plot of the PfTrxR constructs (enzymes 7, 8, 11). (D) Plots
of the PfTrxR hybrid constructs (enzymes 9-11).
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Table 5.
Enzyme
abbreviation

Enzyme
number

Ascorbyl radicalreductase activity (pmol
NADPH/min)a

mTrxR2GCUG
mTrxR2GCCG
mTrxR2Δ8
DmTrxRSCUG
DmTrxRSCCS
DmTrxRΔ8
PfTrxRGCGGGKUG
PfTrxRGCGGGKCG
PfTrxRGCUG
PfTrxRGCCG
PfTrxRΔ7

1

350 ± 4

Ascorbyl radicalreductase activity (mol
NADPH/min/mol
enzyme)b
7 ± 0.01

2

NDc

ND

3
4

ND
365 ± 15

ND
7±1

5

ND

ND

6
7

ND
310 ± 20

ND
6 ± 0.01

8

ND

ND

9

1500 ± 100

31 ± 2

10

ND

ND

11

ND

ND

Table 5. Calculated ascorbyl radical-reductase activities of the thioredoxin reductases in
this study.a Activity is recorded as pmoles of NADPH oxidized per min. bActivity is
recorded as moles of NADPH oxidized per min per mole of enzyme. cNo activity
detected.
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Figure 35.
A

B

C

D

Figure 35. Plots of A340 vs. time for DHAA-reductase activity assays for the thioredoxin
reductase enzymes in this study. For each plot, the red trace is the Sec-containing
enzyme, the blue trace is the Cys-containing enzyme, the green trace is the truncated
enzyme, and the black trace is the control. Each trace is the average trace of three
experiments. (A) Plot of the mTrxR2 constructs (enzymes 1-3). (B) Plot of the DmTrxR
constructs (enzymes 4-6). (C) Plot of the PfTrxR constructs (enzymes 7, 8, 11). (D) Plots
of the PfTrxR hybrid constructs (enzymes 9-11).
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Table 6.
Enzyme
abbreviation

mTrxR2-GCUG
mTrxR2-GCCG
mTrxR2Δ8
DmTrxRSCUG
DmTrxR-SCCS
DmTrxRΔ8
PfTrxRGCGGGKUG
PfTrxRGCGGGKCG
PfTrxR-GCUG
PfTrxR-GCCG
PfTrxRΔ7

Enzyme
number

DHA-reductase
activity
(pmol
NADPH/min)a

DHA-reductase activity
(mol NADPH/min/mol
enzyme)b

1
2
3
4

500 ± 40

4 ± 0.3

b

ND
ND

ND

1420 ± 140

11 ± 1

ND

5
6
7

ND
ND

ND

1030 ± 100

8±1

8

ND

ND

9
10
11

5640 ± 140

45 ± 1

ND
ND

ND

ND

ND

Table 6. Calculated DHA-reductase activities of the thioredoxin reductases in this study.
a
Activity is recorded as nmoles of NADPH oxidized per min. bActivity is recorded as
moles of NADPH oxidized per min per mole of enzyme. cNo activity detected.
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Figure 36.

Figure 36: Model for electron transfer to cytochrome c in Sec-containing TrxRs and
truncated TrxRs. (left) In full-length TrxRs, the Sec residue is on a C-terminal tail and is
reduced to the selenolate by the N-terminal redox center. The selenolate is capable of
direct one-electron transfer to Fe3+ of cytochrome c, forming a relatively stable selanyl
radical. (right) When the C-terminal tail is removed from the enzyme, cytochrome c can
bind very close to the enzyme-bound FADH2, which can catalyze the transfer of one
electron directly to Fe3+ of cytochrome c.
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Figure 37.

Figure 37: Possible model for the reduction of DHAA to ascorbic acid by Sec-containing
TrxR. As shown in the figure, the reduction could take place by either a 2-electron
reaction mechanism, or two, sequential one-electron reaction mechanisms.
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Chapter 5:
The Reversibly of Sec

Figure 38. The reversibility of Sec. The biological significance of Sec is an open
question. Through out this thesis we have discussed the ability of Sec to reverse
oxidation. How the chemical reversibility of Sec may not just be applicable to oxidation
but may extend to other biologically relevant modifications such as succination. We will
discuss this in the following chapter.
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Conclusions
This project was able to successfully complete all three specific aims. The
completion of these goals has allowed for a better understanding of the gains of function
that Sec imparts to proteins and helps to establish the biological importance of Sec.

Mechanism of Protection in TrxR
Aim 1 was to investigate the mechanism by which Sec conveys resistance to
oxidative inactivation in TrxR. We demonstrated that the adjacent Cys residue of the Cterminal redox site does indeed act to resolve oxidation of Sec. Our results suggest that
resolution of oxidation in Sec enzymes is much quicker then that in the Cys enzymes.
This is most likely the result of the increased electrophilicity of selenenic acid relative to
that of sulfenic acid. The increase in reactivity allows for resolution of oxidation more
rapidly and most likely prevents overoxidation which would result in enzyme
inactivation. While it is clear from our studies that this is the mechanism of how mTrxR
resists oxidative inactivation, there is a question of by what mechanism do other Sec
enzymes resist over oxidation. Evidence of a similar mechanism is observed in GPx. Sec
GPxs do not possess a resolving Cys residue (as reviewed in 205). While there is no
intrinsic resolving residue, the coenzyme glutathione functions in this manner as it will
attack the selenenic acid resulting in a mixed selenosulfide which is then resolved by an
additional molecule of glutathione (206). Interestingly Cys TrxRs are not peroxidases.
This maybe a result of the c-terminal Cys residue, in the motif XCCX, being
overoxidized rapidly. Our mass spectrometry results suggest that this residue becomes
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permanently overoxidized to sulphonic acid or DHA and provides evidence for the rapid
overoxidation of this residue.
Though our results provide evidence that selenenic acid is readily resolved by
TrxR, the question of whether Sec TrxRs can use seleninic acid persists. There is
evidence that TrxR can use these oxidation states (84). Mutant Sec enzymes have also
been shown to be able to utilize this higher oxidation state (73,75). However, there is no
evidence that any WT Sec enzyme is able to utilize seleninic acid. During our
investigations into the reactivity of dimedone toward different oxidations states we
discovered that dimedone could react with seleninic acid which resulted in the formation
of a dimedone dimer. I attempted to use dimedone to detect seleninic acid in the enzyme.
However, no dimer was detected. This may be due to selenenic acid being resolved
before Sec is further oxidized. Another possibility is that very little dimer was generated
and resulted in an undetectable signal. More research is needed to determine if WT Sec
enzymes can indeed use higher oxidation states.
Our research has allowed us to elucidate the mechanism by which Sec conveys
resistance to overoxidation. Though our investigation focused on TrxR, this mechanism
seems likely to explain resistance to oxidative inactivation in other selenoproteins. By
elucidating the mechanism of resistance, we have provided chemical evidence in support
of our theory that Sec was selected for, in part, its ability to provide resistance to
overoxidation.
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Dimedone as an Oxidation State Probe of Selenium
Aim 2 was to investigate the reactivity of dimedone towards selenenic acid and
seleninic acid. We were able to determine that dimedone can indeed label selenenic acid.
However, this bond was labile to nucleophilic attack. This is in keeping with previous
reports demonstrating the susceptibility of -keto selenides towards thiols and selenols
(156, 157, 158, 159, 160, 161, 162). Because the Sec-dimedone label is an α-diketo
selenide, this bond should be weaker then the previously reported compounds. When
dimedone labeled peptide, PTVTGAUG, was treated with TCEP, BMe, or DTT the
dimedone label was removed. Furthermore, when cystine or selenocystine where used in
place of TCEP, BMe, or DTT the dimedone label was still removed. These results
indicate that the dimedone-Sec bond is not stable. Interestingly when we attempted to
inhibit mTrxR with dimedone we could not, but we were able to partially inhibit the
mutant enzyme, mTrxR-GGUG. This enzyme has a glycine residue in place of the Cys
residue found in the WT enzyme (GCUG). We hypothesize that the loss of the Cys
residue is the reason we can partially inhibit the mutant enzyme as the Cys residue could
be acting to resolve the dimedone adduct in a similar fashion to DTT or BMe. Because
the mutant enzyme does not have this residue, its ability to resolve the dimedone bond is
impaired. These results suggest that dimedone should not be used as an indicator of
selenenic acid as the dimedone-Sec bond is very labile.
In addition to determining the reactivity of dimedone toward selenenic acid we
discovered that dimedone was able to react with selenininic acid as well. We believed
that selenininic acid would react with dimedone as these species are known to act as
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weak oxidizing agents (169, 170). Using benzeneselenininic acid we were able to
determine that dimedone does react with selenininic acid. However unlike with selenenic
acid this reaction does not result in an adducted selenium, but rather it results in the
formation of a dimedone dimer and a deselenide. This was a very interesting result as it is
known that dimedone does not react with sulfinic acid. The ability of dimedone to act as
indicator of seleninic acid is a potentially useful discovery as it allows for the study of
this oxidation state in selenoproteins. Discovery of this chemistry could lead to the
development of more reactive and water-soluble compounds capable of reacting with
seleninic acid.

Single Electron Reductions, TrxR, and Sec
Aim 3 was the investigation into the dependence of TrxR on Sec for the reduction
of single electron reductions. We demonstrated that TrxR requires Sec for single electron
reductions of cytochrome c, the ascorbyl radical, and the potential single electron
substrate DHAA. WT mTrxR2 along with the Sec mutants of DmTrxR and PfTrxR could
reduce the ascorybyl radical, cytochrome c, and DHAA. Interestingly the truncated
versions of these enzymes could reduce cytochrome c. We hypothesize that this is due to
direct reduction of cytochrome c by the tightly bound flavin co-enzyme. It is known that
flavins can directly reduce cytochrome c (200). However, no Cys enzymes were able to
reduce the ascorbyl radical or DHAA. This result suggests that TrxR is dependent upon
Sec to catalyze single electron transfers. An interesting aspect of these results is the
finding that only Sec TrxRs can reduce DHAA. There are Cys enzymes that can reduce
DHAA, but in doing so they form a covalent intermediate with DHAA (201, 202). The
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inability of Cys TrxRs to reduce DHAA suggests that the reduction of this compound
involves two single electron transfers. This provides further evidence that TrxR is
dependent on Sec for single electron transfers.
These results provide evidence for Koppenols theory that Sec may be
incorporated into proteins due to the increased stability of the corresponding radical (69,
70). Only Sec TrxRs could catalyze single electron reductions. This maybe due to the
ability of Sec to form stable radicals whereas the Cys enzymes may not be able to readily
form radicals. The ability of Sec TrxR to catalyze the reduction of single electron
substrates has been demonstrated to be biologically relevant (72). These results along
with the evidence that Sec imparts resistance to oxidative inactivation indicate that the
chemical properties of Sec can impart several biologically import functions to protein and
may not have evolved to just fill a single purpose.

The Reversibility of Sec
As has been discussed in detail in this thesis our lab has used TrxR to provide
evidence that Sec confers resistance to over oxidation. The reaction of Sec with oxygen is
readily reversible owing to Secs ability to readily attack electrophiles (nucleophilicity)
while oxidation of Sec is readily reversible due to Secs electrophilicity. This property of
reversibility is not specific for oxidation but can been seen in additional biologically
relevant reactions. For example, the Sec containing protein, selenoprotein K is capable of
transferring palmitoyl groups to protein targets in the endoplasmic reticulum (207).
During the initial step palmitoyl groups are attached to selenprotein K via selenoesters.
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The palmitoyl groups are transferred to target Cys residues via transesterification
reactions that result in the formation of more stable thioesters (207). The reversibility of
Sec also plays a significant role in the innate immune response. Hypothiocyanous acid
(HOSCN) is an oxidant that is generated by the immune system to deal with bacterial
infections. This oxidant is specific for protein thiols and can irreversibly oxidize Cys
residues. Mammalian cells are resistant to this oxidant as mTrxR is cytoprotective as it
can turn over HOSCN (208). When HOSCN reacts with mTrxR it results in the formation
of Sec-SCN. This can either be resolved by the adjacent Cys residue or in can be
hydrolyzed resulting in the formation of seleneninic acid which is then resolved.
Bacterial TrxR is a Cys enzyme and thus does not provide protection against HOSCN as
it is inactivated. The realization of the biological significance of Sec reversibility has
caused us to begin looking into additional physiological events that may take advantage
of Sec. One potential event is protein succination.
Protein succination is a recently discovered post translational modification that
forms as a result of a Michael addition reaction between the Krebs cycle intermediate
fumarate and Cys. This reaction results in the formation of the stable S-(2-succino)adduct (209, 213). Currently over 180 Cys residues have been shown to undergo
succination (214). An example of one such protein that under goes succination is
GAPDH which results in its inactivation (210). It has also been shown to inactivate
protein disulfide isomerase (211). Lys residues are also known to form adducts with
succinate (215). This process, known as succinylation, is believed to be an enzyme
catalyzed reaction between Lys residues and succinyl-CoA (215). Unlike with Cys
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residues succination of Lys resiudes can be repaired by the sirtuin class of deacetylases
(216). Given the irreversibility of Cys succination, it is unsurprising that these
modifications have been implicated in numerous diseases (211, 217). For example,
succination has been shown to occur during metabolic diseases such as diabetes and it is
believed to be involved in oxidative stress (211). It may also play a role in neurological
disorders as well (217). Recently it has been shown that the gram-positive bacteria
Bacillus subtilis is able to repair the S-(2-succino)-adduct in a multistep process that
results in the regeneration of free Cys (213). It is believed that the key enzyme in this
pathway, the putatative monooxygenase YxeK, is not present in mammals but is present
in many types of bacteria, arceha, and certain types of fungus (213). Interestingly the
dimethyl ester derivative of fumarate, dimethyl fumarate, is a Food and Drug
Administration approved therapy for multiple sclerosis and most likely acts by
irreversible adducting thioredoxin on a Cys residue (212). Furthermore, this compound
has been shown to adduct glutathione as well (212). Due to the chemical reversibility of
Sec we are currently investigating whether Sec can be succinated and if this modification
is reversible. In the next section I will discuss some preliminary experiments I have
conducted in order to investigate this.

Preliminary Studies of Sec Reactivity Toward Fumarate
*Note all methods for the experiments discussed in this section appear in
Appendix C. Inactivation of mTrxR2 and DmTrxR with Fumarate. In order to determine if
mTrxR2 is inhibited by fumarate we incubated the enzyme with 1.2mM fumarate for
20mins. Fumarate did not inhibit the enzyme (Figure 39a). When the same experiments
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were conducted with DmTrxR the enzyme lost about ~18% activity (Figure 39b). We
decided to further investigate the inactivation of these enzyme by incubating the reactions
at 37°C. mTrxR2 did not lose any activity when heated (Figure 39a). Interestingly,
DmTrxR lost approximately 30% of its activity when samples were incubated at 37°C
(Figure 39b).
Fumarate Adduction of Thioredoxin and Selenocysteine. We wanted to determine
if the enzyme could reduce succinated Sec or Cys compounds. To investigate this, we
incubated mTrxR2 with fumarate and thioredoxin or selenocystine (Figure 40). When
mTrxR2 was assayed with fumarate and thioredoxin there was a loss of approximately
18% activity compared to the no fumarate control. However, when mTrxR2 was assayed
with selenocystine and fumarate there was a ~20% increase in activity when compared to
the no fumarate control. As a further control we assayed mTrxR2 with H2O2 and
fumarate. This was done as mTrxR2 requires an intact Sec residue to have peroxidase
activity. When this experiment was done there was no difference in activity between the
fumarate treated enzyme and the no fumarate control enzyme (Figure 40). Interestingly,
when DmTrxR was assayed with fumarate and selenocystine you also see an increase in
activity of about 30%.
Detection of Sec Fumarate adduct. Based on the results discussed above we wanted to
determine if ww could detect the Sec-fumarate adduct. In order to do this we treated the
peptide, PTVTGAUG, with fumarate. When the sample was analyzed via mass
spectrometry were able to detect the ion, 869.4 m/z, corresponding to the succinated
peptide (Figure 41).
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Inactivation of TrxR by Fumarate. When mTrxR2 was incubated with fumarate the
enzyme did not lose any activity (Figure 39a). Interestingly, when DmTrxR was exposed
to fumarate the enzyme lost activity with the loss of activity increasing when the
reactions were incubated at 37°C (Figure 39b). The difference in sensitivity to fumarate
exposure is most likely due to the Sec containing mTrxR2 being able to resolve
succination while the Cys enzyme is unable to do so. This results in the inactivation of
DmTrxR. This conclusion is supported by our experiments with selenocystine and
thioredoxin (Figure 40). When selenocystine is used as a substrate there is an increase in
activity when fumarate is present. This is most likely due to the adduction of free Sec that
is formed by reduction of selenocystine. We have demonstrated that Sec will react with
fumarate using our peptide model (Figure 41). When the Sec is adducted it then acts as a
substrate for DmTrxR and mTrxR2 as the adduction is on selenium which appears to be
reversible. Conversely when we use thioredoxin as substrate with fumarate present there
is a loss of activity (Figure 40). This loss of activity is most likely due to succination of
the Cys residues of thioredoxin. Because succination on sulfur is not reversible, the
succinated thioredoxin is no longer a substrate for mTrxR2. This results in the observed
loss of activity. From these results it appears that succination of Sec is reversible.

Sec, Fumarate, and Eletrophilic Stress
It has previously been demonstrated that Sec bonded to a carbon that is α to a
carbonyl is reversible (136, 161) owning to the lability of the bond. In this study we have
shown that succination of Sec, a reaction that leads to Sec being bonded to a carbon α to a
carbonyl, is reversible. This is an important discovery as protein succination has been
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shown to be a physiologically relevant modification (211, 217). The ability of Sec
containing mTrxR2 to resist inactivation by fumarate suggests that these proteins may
play a role in dealing with the symptoms of fumarate stress. In addition to fumarate there
are other endogenous electrophiles such as electrophilic lipids that are generated under
conditions of oxidative stress (218). Sec may also provide resistance to other
physiologically relevant electrophiles. This resistance could allow proteins containing
Sec to resist electrophilic stress and remain active. The biological significance of Sec is a
widely debated question. It had previously been thought that Sec imparts a catalytic
advantage to an enzyme however Cys orthologues of Sec enzyme exist. This study
provides evidence that the selection of Sec is impart due to its ability to resist
electrophilic stress. These findings further help to establish the biological significance of
Sec.
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Figure 39.

Figure 39. Figure 1. % Peroxidase activity remaining (a) or % DTNB reductase activity
remaining following exposure to 1.2mM fumarate at room temp or incubated at 37°C.
Error bars represent standard error of 3 trails.
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Figure 40.

Figure 40. % Activity remaining relative to control following exposure to 600 uM
fumarate. The substrate used is listed on the x-axis. Error bars represent standard error of
3 trials.
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Figure 41.

Figure 38. m/z spectrum of the reaction between a peptide with the sequence
PTVTGAUG and fumarate. The succinated protein was detected at with an m/z charge of
869.4. While a peptide-BMe adducted was detected at 829.4
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Appendices
A. Abbreviations

ATP, adenosine triphosphate; ΒMe, 2-mercaptoethanol, Cys, cysteine; pm, picometers;
DHAA, dehydroascorbate; Dm, drosophila melanogaster; DmTrxR; drosophila
melanogaster thioredoxin reductase; DTT, dithiothreitol; GABA, gamma-aminobutyric
acid; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GPx, glutathione peroxidase;
GR, glutathione reductase; HOSCN, Hypothiocyanous acid; NMR, nuclear magnetic
resonance; PfTrxR, Plasmodium falciparum thioredoxin reductase; PTSK, Ophosphoseryl–tRNA kinase; SBP2, SECIS element binding protein 2; SeMet,
selenomethionine; Sec, selenocysteine; SECIS, Selenocysteine incorporation sequence;
Sep-tRNASec, O-phosphoseryl–tRNASec; Ser, serine; SerRS, seryl-tRNA synthetase
SPS2, selenophosphate synthetase 2; TCEP , tris(2-carboxyethyl)phosphine; TrxR,
thioredoxin reductase; TrxR-H, high molecular weight thioredoxin reductase; TrxR-L,
low molecular weight thioredoxin reductase; tRNA, transfer ribonucleic acid; Trx,
thioredoxin; WT, wild type; H2O2, hydrogen peroxide; GSH, glutathione; dimedone, 5,5dimethylcyclohexane-1,3-dione; LCMS, liquid chromatography-mass spectrometry; Ser;
mTrxR, mammalian; Sec-SeO2-, selenocysteine-seleninic acid; Ala, alanine; HED,
hydroxyethyl disulfide; TLC, thin-layer chromatography; HPLC, high-performance
liquid chromatography; APCI, atmospheric-pressure chemical ionization; ESI,
electrospray ionization; PhSeO2H, benzeneseleninic acid; MeSeO2H, methaneseleninic
acid; Gly, glycine; Carb; carbamidomethylation; CBD, Chitin-binding domain; DHA,
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Dehydroalanine; DTNB, 5,5'-dithio-bis-[2-nitrobenzoic acid]; E. coli, Escherichia coli
EDTA, ethylenediaminetetraacetic acid; Fmoc, 9-fluorenylmethoxycarnbonyloxy; HOBr,
Hypobromous acid; IAA, Iodoacetamide; mTrxR1, mammalian cytosolic thioredoxin
reductase; mTrxR2, mouse mitochondrial thioredoxin reductase; MEF, mouse embryonic
fibroblasts; NaCl, sodium chloride; NADPH, nicotinamide adenine dinucleotide
phosphate; MOPS, (3-(N-morpholino)propanesulfonic acid); NMA, Nmethylmercaptoacetamide; Sec, Selenocysteine; SO3, sulfonic acid; reductase; Asc,
ascorbic acid or ascorbate; AO, ascorbate oxidase; FAD, flavin adenine dinucleotide;
FADH2, flavin adenine dinucleotide reduced; protein disulfide isomerase, PDI; SDSPAGE, sodium dodecylsulfate polyacrylamide gel electrophoresis; SOD, superoxide
dismutase; O2•–, superoxide radical anion; Tris, tris-(hydroxymethyl)aminomethane; U,
one-letter code for selenocysteine
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B. List of Materials
L-ascorbic acid sodium salt, and selenocystine were purchased from Acros (Geel,
Belgium). Fumarate, DHAA, bovine cytochrome c, SOD from bovine erythrocytes,
ascorbate oxidase from Cururbita sp., catalase, DTNB, trypsin, and iodoacetamide,
methaneseleninic acid, benzeneseleninic acid, 2-HED, NMA were all purchased from
Sigma Aldrich (St. Louis, Missouri). NADPH was purchased from Applichem
(Darmstadt, Germany). Potassium phosphate, hydrogen peroxide, diethyl either, Lcysteine, EDTA, DTT, and cystine were purchased from Fisher Scientific (Fair Lawn,
New Jersey). Sodium hypobromite was purchased from Aqua Solutions (Deer Park,
Texas). All enzyme kinetic assays were done using a Cary 50 UV-Vis spectrophotometer
(Walnut Creek, California). All assays were carried out at room temperature.
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C. Methods for Fumarate Studies
Succination of PTVTGAUG. Peptides were synthesized with the Sec residue initially
protected as the p-methoxybenzyl (Mob) derivative. The Mob group on Sec was replaced
with a 5-nitro-2-pyridinesulfenyl (5-Npys) group by addition of DTNP to the cleavage
cocktail. Upon addition of DTNP, the Mob protecting group on Sec is replaced with 5Npys. In order to label the peptide, 500uM of peptide was incubated with 450uM
ascorbate to remove the 5-NPYS protecting group, 500mM fumarate, and 1M BMe in
50mM ammonium bicarbonate pH 7.0 for 20mins at room temperature. All samples were
then analyzed via LC-MS.
Determining Peroxidase Activity. 100nM mTR was assayed with 600uM fumarate and
10mM H2O2 in 50 mM potassium phosphate buffer, pH 7, 1 mM EDTA, and 200 M
NADPH. The final reaction volumes were 500 L. Activity was determined by
measuring NAPDH consumption spectrophotometrically for 2mins at 340 nm using an
extinction coefficient of 6220 M-1 cm-1. Control experiments were conducted in the same
manner except no fumarate was present.
Trx and Selenocystine Reductase Activity. 10nM mTrxR2 or 50nM DmTrxR assayed
were assayed with 600uM fumarate and 90uM Trx or 90uM selenocystine in 50 mM
potassium phosphate buffer, pH 7, 1 mM EDTA, and 200 M NADPH. The final
reaction volumes were 500 L. Activity was determined by measuring NAPDH
consumption spectrophotometrically for 2mins at 340 nm using an extinction coefficient
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of 6220 M-1 cm-1. Control experiments were conducted in the same manner except no
fumarate was present.
Inactivation of TrxR with Fumarate. 100nM mTrxR2 or 100nM DmTrxR was incubated
with 1 mM EDTA, and 200 M NADPH in 50 mM potassium phosphate buffer pH 7 for
5mins. Following 5mins 600uM or 1.2mM sodium fumarate in 50mM phosphate pH 7.0
was added and samples were incubated for 20mins. For samples that were heat, the
20min incubation took place in a water bath set at 37°C. Final volume for all assays was
500µl. Following the incubation period mTrxR2 was assayed with 10mM H2O2 while
DmTrxR was assayed with 100µM DTNB. Activity for mTrxR2 was determined by
following NAPDH consumption spectrophotometrically at 340 nm. Activity of DmTrxR
was determined by following DTNB reduction spectrophotometrically at 412 nm.
Control experiments were conducted in the same manner except no fumarate was added.
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